Other pleural conditions

J10_PLEUROTH

No definition available.

Endpoint definition

↥

Endpoint definition steps	FinnGen
Phenotype data	520210
1. Apply sex-specific rule None	520210
2. Check conditions None	520210
3. Check pre-conditions, main-only, mode, registry filters Registry filters: Hospital discharge: ICD-10 — J94 Hospital discharge: ICD-9 — 511 Hospital discharge: ICD-8 — 511 Hospital discharge: excluded ICD-9 — 5111 Hospital discharge: excluded ICD-8 — 511[1-2] Cause of death: ICD-10 — J94 Cause of death: ICD-9 — 511 Cause of death: ICD-8 — 511 Cause of death: excluded ICD-9 — 5111 Cause of death: excluded ICD-8 — 511[1-2] 2 out of 7 registries used, show all original rules.	4080
4. Check minimum number of events None	4080
5. Include endpoints None	4080
6. Filter based on genotype QC (FinnGen only)	4080

Control definitions (FinnGen only)

Control exclude: J10_PLEURA

Extra metadata

Level in the ICD hierarchy: 3
First used in FinnGen datafreeze: DF2
Parent code in ICD-10: J90-J94
Name in latin: Aliae morbositates pleurae

NAME	J10_PLEUROTH
CONTROL_EXCLUDE	J10_PLEURA
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS
SEX
INCLUDE
PRE_CONDITIONS
CONDITIONS
OUTPAT_ICD
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10	J94
HD_ICD_9	511
HD_ICD_8	511
HD_ICD_10_EXCL
HD_ICD_9_EXCL	5111
HD_ICD_8_EXCL	511[1-2]
COD_MAINONLY
COD_ICD_10	J94
COD_ICD_9	511
COD_ICD_8	511
COD_ICD_10_EXCL
COD_ICD_9_EXCL	5111
COD_ICD_8_EXCL	511[1-2]
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO
CANC_TOPO_EXCL
CANC_MORPH
CANC_MORPH_EXCL
CANC_BEHAV

Similar endpoints

↥

List of similar endpoints to Other pleural conditions based on the number of shared cases.

Similar with more cases:

Similar with less cases:

None

Case counts by codes

↥

FinnGen case counts by registry codes:

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

Key figures

	All	Female	Male
Number of individuals
Whole population	35764	13302	21866
Only index persons	25352	10084	15268
Unadjusted period prevalence (%)
Whole population	0.53	0.38	0.61
Only index persons	0.50	0.37	0.58
Median age at first event (years)
Whole population	67.99	70.47	66.53
Only index persons	68.38	70.79	66.78

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	4080	1377	2703
Unadjusted period prevalence (%)	0.95	0.47	1.19
Median age at first event (years)	67.05	66.67	67.24

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS (R11)

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

Matched cohort

Matched cases
3666: Matched controls
36660

Code

Vocabulary

Description

Odds Ratio

-log₁₀(p)

N matched cases

N matched controls

5119X

ICD-9 Finland

Pleurisy, Unspecified pleural effusion

+∞

323.0

358

J94.8

ICD-10 Finland

Other specified pleural conditions

8856.6

323.0

2119

J94.2

ICD-10 Finland

Haemothorax

1817.3

323.0

321

GAA10

NOMESCO Finland

Intercostal insertion of pleural drainage tube

45.0

323.0

530

137

GA4YT

NOMESCO Finland

Puncture of pleura with ultrasound guidance

28.9

323.0

777

338

J90

ICD-10 Finland

Pleural effusion, not elsewhere classified

1621.6

323.0

1203

J94.9

ICD-10 Finland

Pleural condition, unspecified

2300.0

323.0

553

GA1AE

NOMESCO Finland

Ultrasound examination of thorax

19.4

262.9

411

237

GD1AA

NOMESCO Finland

Thorax X-ray examination

3.3

247.8

2245

11951

GA4AT

NOMESCO Finland

Cathetrisation of pleural cavity with ultrasound guidance

41.0

244.2

309

J92.0

ICD-10 Finland

Pleural plaque with presence of asbestos

190.6

240.4

249

TGA30

NOMESCO Finland

Thoracocentesis

84.6

224.8

252

C03CA01

ATC

furosemide; systemic

3.1

224.1

1942

9742

5110B

ICD-9 Finland

Pleurisy, Without mention of effusion or current tuberculosis[PLEURA-ADHEESIOT]

+∞

223.2

212

R06.0

ICD-10 Finland

Dyspnoea

3.3

216.7

1443

5955

GD1UA

NOMESCO Finland

Thorax X-ray examination outside radiological department

3.7

202.0

1072

3663

UGC12

NOMESCO Finland

Flexible bronchoscopy

5.0

186.0

672

1583

GD1BD

NOMESCO Finland

Thorax extensive CT-examination

6.8

184.0

502

839

J18.9

ICD-10 Finland

Pneumonia, unspecified

2.9

179.9

1526

7212

GD1PA

NOMESCO Finland

X-ray examination of the lungs in one projection

4.3

159.9

674

1833

R91

ICD-10 Finland

Abnormal findings on diagnostic imaging of lung

3.9

155.1

725

2162

J96.1

ICD-10 Finland

Chronic respiratory failure

+∞

148.9

142

GAC00

NOMESCO Finland

Biopsy of pleura

174.8

144.6

151

FB1BD

NOMESCO Finland

Extensive CT examination of arteria pulmonalis

4.7

140.8

527

1263

I50.9

ICD-10 Finland

Heart failure, unspecified

3.0

139.9

1022

4234

Z51.5

ICD-10 Finland

Palliative care

4.6

135.8

520

1273

JN4BD

NOMESCO Finland

Extensive body CT

3.6

135.0

714

2335

GAA96

NOMESCO Finland

Other open or percutaneous drainage of pleural cavity

75.8

134.6

153

N02AA05

ATC

oxycodone; systemic

3.0

132.6

941

3806

GD1AD

NOMESCO Finland

Thorax CT examination

6.3

132.5

375

647

A03FA01

ATC

metoclopramide; systemic, rectal

2.7

118.2

992

4408

H02AB06

ATC

prednisolone; systemic

2.2

117.0

1924

12089

51101

ICD-8 Finland

Pleurisy, Adhaesiones pleurae

+∞

116.2

111

GAC01

NOMESCO Finland

Endoscopic biopsy of pleura

392.7

115.1

115

H02AB02

ATC

dexamethasone; systemic

3.4

107.2

579

1896

C45.0

ICD-10 Finland

Mesothelioma of pleura

87.9

106.7

119

GD1BA

NOMESCO Finland

Extensive X-ray examination of thorax

13.9

101.6

179

135

C78.2

ICD-10 Finland

Secondary malignant neoplasm of pleura

61.8

97.5

114

J92.9

ICD-10 Finland

Pleural plaque without asbestos

205.4

96.9

100

J86.9

ICD-10 Finland

Pyothorax without fistula

18.5

96.1

151

A49.9

ICD-10 Finland

Bacterial infection, unspecified

2.9

94.7

686

2737

WD125

NOMESCO Finland

Demanding cystostatic therapy of methastized malignancy

5.1

91.9

311

657

JN4AD

NOMESCO Finland

Body CT examination

3.4

90.9

482

1543

WD105

NOMESCO Finland

Cystostatic therapy of methastized malignancy

5.2

88.0

290

594

J01MA14

ATC

moxifloxacin; systemic

3.3

86.6

489

1638

A04AA01

ATC

ondansetron; systemic, rectal

4.0

86.6

377

1022

130

Kela drug reimbursment

Malignant tumour

3.0

86.5

554

2028

TPH04

NOMESCO Finland

Cathetrisation of vein

2.3

83.8

951

4824

J44.8

ICD-10 Finland

Other specified chronic obstructive pulmonary disease

2.7

83.7

656

2727

J01MA12

ATC

levofloxacin; systemic

2.3

81.8

930

4711

GD1DD

NOMESCO Finland

High resolution CT examination of lungs

4.6

80.0

298

695

C03DA01

ATC

spironolactone; oral

2.7

77.3

618

2587

I50.0

ICD-10 Finland

Congestive heart failure

2.8

75.5

533

2068

51109

ICD-8 Finland

Pleurisy, Sicca NUD

+∞

75.2

GA3AT

NOMESCO Finland

Pleural cytology with ultrasound guidance

37.1

73.2

JN3AE

NOMESCO Finland

Abdominal ultrasound examination

2.5

71.4

626

2751

GD1QA

NOMESCO Finland

Supine thorax X-ray examination

2.2

71.2

854

4394

J94.0

ICD-10 Finland

Chylous effusion

+∞

70.0

J96.0

ICD-10 Finland

Acute respiratory failure

180.9

68.3

R18

ICD-10 Finland

Ascites

7.2

68.3

172

249

J94.1

ICD-10 Finland

Fibrothorax

+∞

65.8

B01AB10

ATC

tinzaparin; parenteral

3.3

65.3

360

1173

TPX10

NOMESCO Finland

Implantation of vascular injection port

5.2

63.7

206

411

GD5BD

NOMESCO Finland

Thorax and upper abdomen combined extensive CT examination of

6.2

63.1

177

297

R03BB04

ATC

tiotropium bromide; inhalant

2.5

62.6

543

2356

A04AA02

ATC

granisetron; systemic, transdermal

3.5

61.3

303

907

FM1AE

NOMESCO Finland

Standard cardiac ultrasound examination

2.1

61.0

836

4520

B01AB05

ATC

enoxaparin; parenteral

1.9

60.8

1219

7635

ZX120

NOMESCO Finland

Intravenous

2.7

60.5

457

1831

FM1EE

NOMESCO Finland

Extensive structural and functional ultrasound examination of heart

2.0

60.0

949

5431

A02BC02

ATC

pantoprazole; systemic

1.8

59.3

2317

18001

WX892

NOMESCO Finland

Monitored bed care

2.9

59.2

406

1530

C07AB07

ATC

bisoprolol; oral

1.8

59.2

1985

14692

R50.9

ICD-10 Finland

Fever, unspecified

2.3

58.0

617

2967

C79.8

ICD-10 Finland

Secondary malignant neoplasm of other specified sites

4.3

56.5

223

547

B01AA03

ATC

warfarin; systemic

1.9

56.2

1119

6947

R02

ICPC

Shortness of breath/dyspnoea

2.4

54.8

521

2360

R03AC02

ATC

salbutamol; inhalant

1.7

54.6

1688

12063

TPH15

NOMESCO Finland

Insertion of central venous catheter through external or internal jugular vein

3.0

53.6

331

1163

J61

ICD-10 Finland

Pneumoconiosis due to asbestos and other mineral fibres

16.9

53.5

I26.9

ICD-10 Finland

Pulmonary embolism without mention of acute cor pulmonale

3.1

53.2

309

1041

JA3AT

NOMESCO Finland

Cathetrisation of abdominal cavity with ultrasound guidance

7.0

52.0

133

197

WW500

NOMESCO Finland

Blood transfusion

3.8

51.9

237

663

I48

ICD-10 Finland

Atrial fibrillation and flutter

1.8

51.0

1204

7860

WZC00

NOMESCO Finland

Planning of intervention or health care consultation

1.8

50.6

1100

6985

J93.1

ICD-10 Finland

Other spontaneous pneumothorax

504.6

50.5

9052/3-C38.4

ICD-O-3

Epithelioid mesothelioma, malignant of pleura, NOS

504.6

50.5

J15.9

ICD-10 Finland

Bacterial pneumonia, unspecified

2.4

50.2

477

2155

1240

FHL

Bronchoscopy

6.7

49.2

129

198

XG412

NOMESCO Finland

Flow-volume spirometry with bronchospasmolysis

3.2

48.9

276

909

ZXD05

NOMESCO Finland

Urgent procedure

1.8

47.6

1180

7783

WF049

NOMESCO Finland

Radiotherapy of metastasis

3.8

47.4

209

567

TGC00

NOMESCO Finland

Bronchial lavation

4.8

47.1

164

355

UJD10

NOMESCO Finland

Esophagoscopy, gastroscopy and duodenoscopy

1.8

46.7

1127

7356

XF400

NOMESCO Finland

ECG with 12 standard connections

2.0

46.7

757

4313

J93.8

ICD-10 Finland

Other pneumothorax

+∞

45.9

A12AX

ATC

Calcium, combinations with vitamin D and/or other drugs

1.7

45.9

1202

8044

J98.1

ICD-10 Finland

Pulmonary collapse

453.1

45.3

I31.9

ICD-10 Finland

Disease of pericardium, unspecified

14.3

44.9

J44.0

ICD-10 Finland

Chronic obstructive pulmonary disease with acute lower respiratory infection

3.0

44.5

268

924

TPH07

NOMESCO Finland

Cathetrisation of artery

2.3

43.9

467

2221

L03AA13

ATC

pegfilgrastim; parenteral

4.1

43.9

180

458

JN1AE

NOMESCO Finland

Ultrasound examination of upper part of abdomen

2.5

42.8

358

1507

GAC97

NOMESCO Finland

Other endoscopic operation on pleura

41.3

42.5

WX408

NOMESCO Finland

General anesthesy, balanced

1.8

42.0

965

6163

N02AX02

ATC

tramadol; systemic, rectal

1.6

41.4

1547

11351

J01CR02

ATC

amoxicillin and beta-lactamase inhibitor; systemic

1.6

41.3

1537

11261

J91

ICD-10 Finland

Pleural effusion in conditions classified elsewhere

+∞

40.7

N05CF01

ATC

zopiclone; oral

1.7

40.3

1247

8678

J93.9

ICD-10 Finland

Pneumothorax, unspecified

401.7

40.2

GAA31

NOMESCO Finland

Thoracoscopy

22.6

40.1

L01CA04

ATC

vinorelbine; systemic

10.1

39.1

WX700

NOMESCO Finland

Respiratory and circulatory monitoring

1.9

39.1

644

3664

N17.9

ICD-10 Finland

Acute renal failure, unspecified

3.1

38.6

225

755

JN4CD

NOMESCO Finland

Very extensive body CT

3.2

38.5

218

718

XG410

NOMESCO Finland

Flow-volume spirometry

3.4

38.2

196

601

N18.9

ICD-10 Finland

Chronic kidney disease, unspecified

2.4

37.8

348

1538

FM1BE

NOMESCO Finland

Cardiac ultrasound examination through oesophagus

2.5

37.2

304

1259

TK800

NOMESCO Finland

Hemodialysis

4.4

36.8

139

327

R03AK06

ATC

salmeterol and fluticasone; inhalant

2.0

36.8

543

2959

GD5AD

NOMESCO Finland

Thorax and upper abdomen combined CT examination of

7.8

36.6

113

128

Kela drug reimbursment

Cancers of female genital organs

6.7

35.9

141

WX872

NOMESCO Finland

Intensive care

2.7

35.2

253

974

9050/3-C38.4

ICD-O-3

Mesothelioma, malignant of pleura, NOS

47.1

34.7

GD1CT

NOMESCO Finland

Biopsy of the lung with CT guidance

6.0

34.5

168

203

Kela drug reimbursment

Chronic asthma and similar chronic obstructive pulmonary diseases

1.8

34.4

703

4284

5861

FHL

Pleural biopsy or removal of local change

340.2

34.0

B03XA02

ATC

darbepoetin alfa; parenteral

4.4

33.9

128

302

J45.9

ICD-10 Finland

Asthma, unspecified

1.9

33.6

608

3553

PH2AE

NOMESCO Finland

Ultrasound examination of lower leg veins

2.1

33.6

425

2173

GD1ED

NOMESCO Finland

Extensive high resolution CT examination of lungs

3.8

33.2

145

391

WZC30

NOMESCO Finland

Teaching

2.0

33.1

475

2550

J01FF01

ATC

clindamycin; systemic

1.7

33.0

894

5923

138

Kela drug reimbursment

Severe anaemia associated with chronic renal failure

3.8

32.6

142

382

5118X

ICD-9 Finland

Pleurisy, Other specified forms of effusion, except tuberculous

+∞

32.3

A28

ICPC

Limited function/disability NOS

1.8

32.0

691

4276

J44.9

ICD-10 Finland

Chronic obstructive pulmonary disease, unspecified

2.5

31.8

257

1058

M05BX04

ATC

denosumab; parenteral

2.7

31.8

222

841

WX302

NOMESCO Finland

Thoracal epidural anesthesy

2.7

31.7

232

903

123

Kela drug reimbursment

Chronic disorders of vitamin D metabolism

3.7

31.1

141

392

166

Kela drug reimbursment

Dalteparin and tinzaparin (treatment for more than 6 months)

8.5

30.9

S27.1

ICD-10 Finland

Traumatic haemothorax

9.4

30.8

C78.0

ICD-10 Finland

Secondary malignant neoplasm of lung

4.5

30.8

112

255

WD115

NOMESCO Finland

Multiple cystostatic therapy of methastized malignancy

4.7

30.8

108

237

L03AA14

ATC

lipegfilgrastim; parenteral

5.8

30.6

154

FN1AC

NOMESCO Finland

Angiography of heart and/or coronary arteries

1.6

30.4

937

6403

XG470

NOMESCO Finland

Measurement of diffusion capastity of the lungs

3.7

30.4

139

390

WD505

NOMESCO Finland

Simple enzyme inhibitor or similar therapy of methastized malignancy

7.4

30.4

100

TPH90

NOMESCO Finland

Removal of fixed intravenous catheter

5.6

30.1

161

ZXE20

NOMESCO Finland

More than three and less than five hours

1.8

30.0

551

3227

C01AA05

ATC

digoxin; systemic

1.9

29.8

474

2640

I50.1

ICD-10 Finland

Left ventricular failure

2.4

29.8

280

1245

1501

Kela drug reimbursment

Palbociclib

19.0

29.6

N03AX16

ATC

pregabalin; oral

1.7

29.2

774

5070

N02BE01

ATC

paracetamol; systemic, rectal

1.6

29.1

2882

25616

C56.71

ICD-10 Finland

Serous epithelial malignant tumor of the ovary

10.3

28.9

AA1AD

NOMESCO Finland

CT of head and brain

1.6

28.7

919

6329

D38.1

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Trachea, bronchus and lung

3.0

28.6

169

572

JN3BD

NOMESCO Finland

Extensive abdominal CT

2.0

28.3

411

2210

TFC00

NOMESCO Finland

Catheterisation of right atrium or ventricle

4.7

28.3

217

SPAT1254

SPAT

Administration of medicine

1.8

27.9

571

3461

L03AA02

ATC

filgrastim; parenteral

3.5

27.8

133

387

8140/3-C34.9

ICD-O-3

Adenocarcinoma, NOS, of lung, NOS

6.1

27.8

129

SPAT1148

SPAT

Treatment of chronic ulcer or burn

1.8

27.7

554

3333

J84.1

ICD-10 Finland

Other interstitial pulmonary diseases with fibrosis

3.9

27.6

116

303

J44.1

ICD-10 Finland

Chronic obstructive pulmonary disease with acute exacerbation, unspecified

3.1

27.5

158

527

J96.9

ICD-10 Finland

Respiratory failure, unspecified

53.7

27.2

C79.5

ICD-10 Finland

Secondary malignant neoplasm of bone and bone marrow

3.7

27.0

121

334

A06AH03

ATC

naloxegol; oral

5.8

27.0

134

202

Kela drug reimbursment

Connective tissue diseases, rheumatoid arthritis and comparable disease

2.0

26.9

385

2059

J20.9

ICD-10 Finland

Acute bronchitis, unspecified

1.7

26.9

606

3781

A41.9

ICD-10 Finland

Sepsis, unspecified

2.7

26.6

183

687

394

Kela drug reimbursment

Palbociclib

19.2

26.5

TPH20

NOMESCO Finland

Insertion of central venous catheter through subclavian or brachiocephalic vein

3.3

26.5

138

430

R4190

NOMESCO Finland

Nutritional therapy

3.4

26.4

131

393

N02AA01

ATC

morphine; systemic, rectal

4.2

26.4

102

247

D64.9

ICD-10 Finland

Anaemia, unspecified

1.8

26.3

470

2722

R4110

NOMESCO Finland

Physiotherapy

1.6

26.2

890

6197

WD405

NOMESCO Finland

Simple antiboidy therapy of methastized malignancy

3.9

25.7

108

283

A11CC03

ATC

alfacalcidol; systemic

3.4

25.6

127

381

Z2446

NOMESCO Finland

Social worker

2.4

25.6

231

1005

FXA00

NOMESCO Finland

Total cardiopulmonary bypass in normothermia or moderate hypothermia at concurrent surgical procedure

2.5

25.6

202

821

A06AD11

ATC

lactulose; oral

1.7

25.2

645

4164

WF004

NOMESCO Finland

Palliative radiotherapy

3.7

25.0

112

310

J01CA04

ATC

amoxicillin; systemic

1.5

24.9

2469

21453

M04AA01

ATC

allopurinol; systemic

1.7

24.9

604

3841

L01XE33

ATC

[U] palbociclib; oral

23.5

24.8

192

Kela drug reimbursment

Fulvestrant

14.8

24.7

A46

ICD-10 Finland

Erysipelas

1.7

24.6

549

3406

L04AX01

ATC

azathioprine; systemic

3.0

24.5

146

499

N18.8

ICD-10 Finland

Other chronic renal failure

2.9

24.3

156

561

N02AB03

ATC

fentanyl; nasal, sublingual, transdermal

2.4

24.3

223

981

I50

ICD-10 Finland

Heart failure

2.6

24.0

176

686

XX1AT

NOMESCO Finland

Other puncture with ultrasound guidance

6.6

24.0

XF600

NOMESCO Finland

Bloodpressure measurement

2.2

23.8

255

1207

Z71.3

ICD-10 Finland

Dietary counselling and surveillance

2.9

23.8

152

544

XX3DW

NOMESCO Finland

Time consuming IT work

1.9

23.6

363

1988

J01DB01

ATC

cefalexin; oral

1.5

23.6

2598

22900

R04.2

ICD-10 Finland

Haemoptysis

2.7

23.5

168

646

DM1QA

NOMESCO Finland

Paranasal sinuses X-ray examination in one projection

2.8

23.4

160

598

I25.1

ICD-10 Finland

Atherosclerotic heart disease

1.5

23.4

1062

7869

JN3AD

NOMESCO Finland

Abdominal CT examination

2.1

23.3

286

1438

ZXE00

NOMESCO Finland

One hour or less

1.5

23.2

1264

9722

Z49.1

ICD-10 Finland

Extracorporeal dialysis

4.2

23.0

212

C78.6

ICD-10 Finland

Secondary malignant neoplasm of retroperitoneum and peritoneum

6.0

22.9

109

207

Kela drug reimbursment

Chronic arrhythmias

1.6

22.7

641

4236

I31.3

ICD-10 Finland

Pericardial effusion (noninflammatory)

13.6

22.7

N02AA59

ATC

codeine, combinations excl. psycholeptics; systemic

1.4

22.6

1385

10885

Z00.4

ICD-10 Finland

General psychiatric examination, not elsewhere classified

2.4

22.6

206

903

GDA11

NOMESCO Finland

Thoracoscopic biopsy of lung

15.8

22.3

L04AA06

ATC

mycophenolic acid; systemic

4.6

22.0

170

L02BA03

ATC

fulvestrant; parenteral

11.9

22.0

JAL30

NOMESCO Finland

Omentectomy

7.3

21.7

XG466

NOMESCO Finland

Sleep oxymetry

2.9

21.3

130

454

P01BA02

ATC

hydroxychloroquine; oral

2.1

21.1

259

1301

ZXE40

NOMESCO Finland

More than seven and less than nine hours

3.2

21.1

111

350

GAB10

NOMESCO Finland

Antero- or postero-lateral thoracotomy

8.7

21.0

R84

ICPC

Malignant neoplasm bronchus/lung

9.9

21.0

S22.4

ICD-10 Finland

Multiple fractures of ribs

3.3

21.0

108

335

XPX99

NOMESCO Finland

Other diagnostic examination of periferal vessel

2.0

21.0

299

1591

QDB10

NOMESCO Finland

Major dressing of wound of skin of lower limb

2.3

20.9

206

937

KH1AE

NOMESCO Finland

Urinary tract ultrasound examination

2.1

20.9

251

1248

5111B

ICD-9 Finland

Pleurisy, With effusion, with mention of a bacterial cause other than tuberculosis[PLEURITIS EXSUDATIVA ALIA DEFINITA]

+∞

20.8

WX725

NOMESCO Finland

Noninvasive ventilation

2.6

20.7

154

605

127

Kela drug reimbursment

Transplant complication

4.7

20.7

154

W01

ICD-10 Finland

Fall on same level from slipping, tripping and stumbling

1.5

20.5

1043

7865

GD1CD

NOMESCO Finland

Thorax extensive CT-examination

5.4

20.5

117

JA2AT

NOMESCO Finland

Abdominal puncture with ultrasound guidance

5.8

20.5

101

PH1AE

NOMESCO Finland

Ultrasound examination of upper extremity veins

4.3

20.5

183

WX602

NOMESCO Finland

Repeated or continuing anesthesia shots throug a catheter

2.1

20.4

243

1204

WX404

NOMESCO Finland

Intravenous generell anesthesy

1.6

20.3

588

3905

A10AB05

ATC

insulin aspart; parenteral (insulins and analog. for injection, fast-acting)

2.0

20.2

272

1417

WD415

NOMESCO Finland

Demanding antibody therapy of methastized malignancy

4.2

20.2

190

L97

ICD-10 Finland

Ulcer of lower limb, not elsewhere classified

2.4

20.2

170

715

GAC47

NOMESCO Finland

Endoscopic partial decortication of pleura

48.3

20.1

E87.1

ICD-10 Finland

Hypo-osmolality and hyponatraemia

2.4

20.1

176

755

R03AL06

ATC

olodaterol and tiotropium bromide; inhalant

3.8

20.0

231

J84.9

ICD-10 Finland

Interstitial pulmonary disease, unspecified

3.4

20.0

288

ZXE04

NOMESCO Finland

Procedure duration 30 to 39 minutes

2.2

19.8

208

976

R03AK03

ATC

[D] fenoterol & other drugs for obstructive airway dis; inhalant

1.9

19.7

290

1563

ZXE10

NOMESCO Finland

More than one and less than three hours

1.4

19.7

1198

9337

ZXE02

NOMESCO Finland

Procedure duration 10 to 19 minutes

2.5

19.7

161

666

ZXE30

NOMESCO Finland

More than five and less than seven hours

2.2

19.7

207

970

R03AL01

ATC

fenoterol and ipratropium bromide; inhalant

3.0

19.7

114

385

A04AD12

ATC

aprepitant; systemic

4.1

19.6

191

L28

ICPC

Limited function/disability (L)

1.6

19.6

594

3983

Z3231

NOMESCO Finland

Registered nurse

1.5

19.5

923

6844

R53

ICD-10 Finland

Malaise and fatigue

1.5

19.5

701

4897

ZXE03

NOMESCO Finland

Procedure duration 20 to 29 minutes

2.2

19.5

199

922

D38.2

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Pleura

19.5

I70.2

ICD-10 Finland

Atherosclerosis of arteries of extremities

1.7

19.3

455

2856

Z3226

NOMESCO Finland

Physiotherapist

1.6

19.2

603

4076

SPAT1222

SPAT

Counselling/guidance promoting independent living

1.6

19.2

565

3763

L02BG04

ATC

letrozole; oral

2.4

19.1

161

679

L02BA01

ATC

tamoxifen; oral

2.9

19.0

117

411

J01AA02

ATC

doxycycline; systemic

1.4

19.0

2511

22328

117

Kela drug reimbursment

Leukaemia and other malignant diseases of the blood and bone marrow, and malignant diseases of the lymphatic tissue

2.2

18.8

189

867

GD1AT

NOMESCO Finland

Biopsy of the lung with ultrasound guidance

10.1

18.8

WD325

NOMESCO Finland

Demanding therapy of methastized malignancy with biomodifiers

5.2

18.7

113

N05BA04

ATC

oxazepam; oral

1.5

18.6

774

5578

M05.8

ICD-10 Finland

Other seropositive rheumatoid arthritis

2.2

18.6

188

869

A04AA55

ATC

palonosetron, combinations; systemic

3.4

18.5

273

GAC10

NOMESCO Finland

Removal of foreign body from pleural cavity

190.9

18.5

WD305

NOMESCO Finland

Simple therapy of methastized malignancy with biomodifiers

4.6

18.5

141

C34.12

ICD-10 Finland

Malignant tumor of the anterior, bronchial or pulmonary adenocarcinoma

4.1

18.4

174

GD5CD

NOMESCO Finland

Thorax and upper abdomen combined very extensive CT examination of

7.5

18.4

JN3AA

NOMESCO Finland

Abdominal X-ray examination without contrast

2.2

18.3

195

921

K77

ICPC

Heart failure

2.9

18.2

112

394

5010A

ICD-9 Finland

Asbestosis[ASBESTOSIS]

25.1

18.2

NK6QA

NOMESCO Finland

Measurement of bone density from tow or more locations with X-ray

2.2

18.1

187

872

TPH30

NOMESCO Finland

Insertion of central venous catheter through periferal vein

4.0

18.0

182

R03BB01

ATC

ipratropium bromide; inhalant

2.1

18.0

200

962

8461/3-C56.9

ICD-O-3

High grade serous carcinoma of ovary

11.5

18.0

XGX32

NOMESCO Finland

Bronchoscopic ultrasonography

6.9

17.9

Z57.2

ICD-10 Finland

Occupational exposure to dust

20.1

17.7

J01FA06

ATC

roxithromycin; oral

1.4

17.6

1217

9653

C50.4

ICD-10 Finland

Malignant neoplasm: Upper-outer quadrant of breast

6.4

17.6

TGA10

NOMESCO Finland

Needle biopsy of pleura

180.8

17.5

SPAT1262

SPAT

Handing over of treatment supplies

1.5

17.3

637

4462

Z51.1

ICD-10 Finland

Chemotherapy session for neoplasm

4.1

17.3

165

WB113

NOMESCO Finland

Multiple adjuvant cytostatic therapy

2.5

17.2

131

525

115

Kela drug reimbursment

Breast cancer

2.1

17.2

208

1037

R95

ICPC

Chron obstructive pulmonary disease

2.7

17.2

115

427

A12AA04

ATC

calcium carbonate; oral

3.4

17.0

243

I20.81

ICD-10 Finland

Other angina pectoris stenosed coronary artery

1.7

17.0

390

2426

SPAT1062

SPAT

Lung clearance therapy

10.1

16.9

H02AB07

ATC

prednisone; oral

1.6

16.8

474

3116

SPAT1263

SPAT

Sampling

1.4

16.7

1309

10582

GAC96

NOMESCO Finland

Other operation on pleura

63.6

16.7

C56.00

ICD-10 Finland

Malignant tumor of the ovary without histology

8.1

16.7

L01BC06

ATC

capecitabine; oral

2.4

16.5

141

599

N18.0

ICD-10 Finland

End-stage renal disease

3.8

16.4

183

N06AX11

ATC

mirtazapine; oral

1.4

16.4

904

6870

FM1DE

NOMESCO Finland

Doppler ultrasound examination of heart

1.7

16.3

346

2099

R11

ICD-10 Finland

Nausea and vomiting

1.9

16.3

256

1413

TQW11

NOMESCO Finland

Vacuum treatment of wound

3.3

16.2

253

XF404

NOMESCO Finland

Ambulatory ECG

1.7

16.1

337

2039

WX882

NOMESCO Finland

High dependency care

2.7

16.1

113

433

A07EC01

ATC

sulfasalazine; oral, rectal

1.9

16.0

250

1376

L01EF01

ATC

palbociclib; oral

18.6

16.0

4912B

ICD-9 Finland

Chronic bronchitis, Obstructive chronic bronchitis[BRONCHITIS OBSTRUCTIVA CUM EMPHYSEMATE]

3.6

16.0

203

J45.1

ICD-10 Finland

Nonallergic asthma

2.0

15.9

219

1150

HA1AE

NOMESCO Finland

Ultrasound examination of mammary glands

2.2

15.8

163

759

I25.9

ICD-10 Finland

Chronic ischaemic heart disease, unspecified

1.6

15.8

499

3369

GAA97

NOMESCO Finland

Other thoracoscopic drainage procedures on pleura

33.5

15.7

Z95.1

ICD-10 Finland

Presence of aortocoronary bypass graft

1.9

15.7

226

1206

T81.4

ICD-10 Finland

Infection following a procedure, not elsewhere classified

1.7

15.6

339

2072

PBL10

NOMESCO Finland

Construction of arteriovenous fistula from radial artery

4.0

15.6

157

J22

ICD-10 Finland

Unspecified acute lower respiratory infection

2.2

15.6

159

737

AN1

Coronary angiography

1.5

15.6

507

3447

0120X

ICD-9 Finland

Other respiratory tuberculosis, Tuberculous pleurisy[TUBERCULOSIS PLEURAE, EPÄILTY]

85.4

15.6

GAC37

NOMESCO Finland

Endoscopic chemical pleurodesis

85.4

15.6

S97

ICPC

Chronic ulcer skin

2.0

15.5

213

1118

C57.9

ICD-10 Finland

Malignant neoplasm: Female genital organ, unspecified

22.1

15.5

D70.82

ICD-10 Finland

Drug-induced neutropenia

3.9

15.5

163

R10.4

ICD-10 Finland

Other and unspecified abdominal pain

1.4

15.5

990

7713

C56

ICD-10 Finland

Malignant neoplasm of ovary

9.0

15.4

C38.4

ICD-10 Finland

Malignant neoplasm: Pleura

38.2

15.4

TGW99

NOMESCO Finland

Other minor procedure in thoracic surgery

12.3

15.3

J01EE01

ATC

sulfamethoxazole and trimethoprim; systemic

1.9

15.3

215

1138

R60.0

ICD-10 Finland

Localized oedema

1.6

15.3

381

2420

K78

ICPC

Atrial fibrillation/flutter

1.7

15.3

339

2084

WX110

NOMESCO Finland

Local anesthesy

1.3

15.2

1908

16512

5862

FHL

Decortication (removal of visceral or parietal pleura)

28.7

15.2

GA2AT

NOMESCO Finland

Pleural biopsy with ultrasound guidance

28.7

15.2

HA1AA

NOMESCO Finland

X-ray mammography

2.0

15.1

184

922

M05.9

ICD-10 Finland

Seropositive rheumatoid arthritis, unspecified

3.0

15.1

301

NE1AA

NOMESCO Finland

Pelvis X-ray examination

1.8

15.0

245

1369

Z2221

NOMESCO Finland

Medical doctor

1.4

15.0

834

6331

C09AA05

ATC

ramipril; oral

1.4

14.9

952

7404

L04AX03

ATC

methotrexate; systemic (immunosuppressants)

1.8

14.9

259

1480

QBC00

NOMESCO Finland

Removal of foreign body from skin of trunk or subcutaneous tissue

15.1

14.9

B03XA03

ATC

methoxy polyethylene glycol-epoetin beta; parenteral

7.0

14.8

WX722

NOMESCO Finland

PEEP

2.1

14.8

168

815

R82

ICPC

Pleurisy/pleural effusion

56.9

14.8

T81.0

ICD-10 Finland

Haemorrhage and haematoma complicating a procedure, not elsewhere classified

1.9

14.7

224

1221

C34.32

ICD-10 Finland

Malignant tumor of the lower lobe, bronchus or lung adenocarcinoma

4.5

14.7

118

GAC46

NOMESCO Finland

Partial decortication of pleura

18.4

14.7

SPAT1255

SPAT

Intravenous administration of medicine

1.9

14.7

229

1259

SPAT1269

SPAT

Other puncture and/or drainage

5.3

14.6

51120

ICD-8 Finland

Pleurisy, Other specified forms of effusion, except tuberculous

+∞

14.6

8500/3-C50.9

ICD-O-3

Infiltrating duct carcinoma, NOS, of breast, NOS

2.3

14.5

131

575

ZXE05

NOMESCO Finland

Procedure duration 40 to 49 minutes

2.1

14.5

164

799

C01DA14

ATC

isosorbide mononitrate; oral

1.4

14.5

756

5670

C34.92

ICD-10 Finland

Malignant tumor in unspecified localization in bronchial and pulmonary adenocarcinoma

8.4

14.5

PG1DE

NOMESCO Finland

Other extensive ultrasound examination of artery

2.1

14.5

163

789

PJD52

NOMESCO Finland

Block dissection of axillary lymph nodes

2.6

14.4

106

417

XQ858

NOMESCO Finland

Oxygen partial pressure measurement

4.4

14.4

116

R07.4

ICD-10 Finland

Chest pain, unspecified

1.4

14.4

884

6819

SPAT1083

SPAT

Initiation and monitoring of IV fluid therapy

2.1

14.4

163

793

V03AE01

ATC

polystyrene sulfonate; oral

3.3

14.4

216

C01BD01

ATC

amiodarone; systemic

2.3

14.3

132

585

A41.5

ICD-10 Finland

Sepsis due to other Gram-negative organisms

2.3

14.3

135

606

1BA04

NOMESCO Finland

22.3

14.2

FEB10

NOMESCO Finland

Decompression and drainage of pericardium

8.6

14.2

YG1BD

NOMESCO Finland

Extensive CT examination of thorax for dose design of radiotherapy

2.6

14.2

104

409

R81

ICPC

Pneumonia

2.4

14.1

120

512

190

Kela drug reimbursment

Lanthanum carbonate, sevelamer and sucroferric oxyhydroxide

4.7

14.1

101

B01AB04

ATC

dalteparin; parenteral

2.0

14.1

183

943

R03AL09

ATC

formoterol, glycopyrronium bromide and beclometasone; inhalant

3.2

14.0

226

A09

ICD-10 Finland

Other gastroenteritis and colitis of infectious and unspecified origin

1.5

14.0

458

3113

N08.39*E11.2

ICD-10 Finland

Non-insulin-dependent diabetes mellitus - Diabetic nephropathy

3.1

13.9

244

I35.0

ICD-10 Finland

Aortic (valve) stenosis

1.7

13.9

276

1642

I48.9

ICD-10 Finland

Atrial fibrillation and atrial flutter, unspecified

1.9

13.8

209

1136

WX730

NOMESCO Finland

Conventional respirator

3.2

13.8

229

A41.0

ICD-10 Finland

Sepsis due to Staphylococcus aureus

2.8

13.8

331

WX000

NOMESCO Finland

Monitoring vital functions without anesthesy

2.3

13.8

129

577

SPAT1253

SPAT

Initiation, adjustment, discontinuation or repetition of medication

1.4

13.7

943

7406

A04.7

ICD-10 Finland

Enterocolitis due to Clostridium difficile

2.4

13.6

114

483

J98.6

ICD-10 Finland

Disorders of diaphragm

+∞

13.5

JJ2AT

NOMESCO Finland

Biopsy of liver with ultrasound guidance

3.0

13.5

271

S27.0

ICD-10 Finland

Traumatic pneumothorax

4.9

13.5

WX002

NOMESCO Finland

Sedation and analgesia

1.4

13.5

635

4661

GAC30

NOMESCO Finland

Artificial pneumothorax

140.5

13.4

C50.81

ICD-10 Finland

Overall malignant tumor of the mammary gland, ductal tumor

4.4

13.4

111

XFP20

NOMESCO Finland

Check up of cardiac pacemaker

1.7

13.4

280

1693

AA1BD

NOMESCO Finland

Extensive CT of head and brain

2.5

13.4

100

399

C56.98

ICD-10 Finland

Malignant tumor of the ovary, indeterminate histology

21.2

13.3

C34.90

ICD-10 Finland

Malignant tumor in unspecified location in bronchus and lung without histology

3.5

13.3

176

N08.39*E10.2

ICD-10 Finland

Insulin-dependent diabetes mellitus - Diabetic nephropathy

5.6

13.3

4859X

ICD-9 Finland

Bronchopneumonia, organism unspecified[PNEUMONIA NUD]

2.4

13.2

108

450

A07AA09

ATC

vancomycin; oral

3.4

13.2

187

A10AE04

ATC

insulin glargine; parenteral

1.6

13.2

319

2010

EB1HA

NOMESCO Finland

Panorama tomography of teeth and jaws or similar X-ray examination

1.3

13.2

1068

8604

J84.8

ICD-10 Finland

Other specified interstitial pulmonary diseases

3.9

13.1

138

E11.7

ICD-10 Finland

Type 2 diabetes mellitus, with multiple complications

1.8

13.1

225

1281

DM1AA

NOMESCO Finland

Paranasal sinuses X-ray examination without contrast

2.5

13.0

103

421

SPAT1137

SPAT

Taking care of patient’s/customer’s hygiene

1.8

13.0

244

1427

LAF16

NOMESCO Finland

Excision of uterus, adnexes and lymph nodes for treatment of ovarian cancer

8.3

13.0

H02AB04

ATC

methylprednisolone; systemic

1.5

13.0

433

2954

WZC20

NOMESCO Finland

Multidisciplinary treatment meeting

2.0

12.9

157

787

FNA01

NOMESCO Finland

Anastomosis to coronary artery from internal mammary artery, one distal anastamosis

1.8

12.8

229

1320

TFB00

NOMESCO Finland

Cathetrisation of pulmonal artery

2.9

12.8

279

1500

FHL

Thoracoscopy

50.2

12.8

D50.9

ICD-10 Finland

Iron deficiency anaemia, unspecified

1.7

12.8

246

1453

F10.1

ICD-10 Finland

Mental and behavioural disorders due to use of alcohol, Harmful use

1.9

12.8

193

1053

TJA10

NOMESCO Finland

Laparocentesis

9.7

12.7

R03BA05

ATC

fluticasone; inhalant

1.5

12.7

486

3419

N02AJ06

ATC

codeine and paracetamol; systemic

1.3

12.7

975

7781

R03BA01

ATC

beclometasone; inhalant

1.5

12.7

407

2753

E87.6

ICD-10 Finland

Hypokalaemia

2.3

12.6

113

495

GAC36

NOMESCO Finland

Chemical pleurodesis

70.1

12.6

SPAT1056

SPAT

Pleural puncture

32.1

12.6

L04AD02

ATC

tacrolimus; systemic (calcineurin inhibitors)

5.5

12.5

R03BA02

ATC

budesonide; inhalant

1.5

12.5

464

3243

C57.8

ICD-10 Finland

Malignant neoplasm: Overlapping lesion of female genital organs

20.1

12.4

Z49.0

ICD-10 Finland

Preparatory care for dialysis

4.0

12.4

120

UJF32

NOMESCO Finland

Coloscopy

1.4

12.4

834

6510

C01DA08

ATC

isosorbide dinitrate; oral, oral aerosol, sublingual, transdermal

1.3

12.4

956

7628

TK810

NOMESCO Finland

Hemofiltration

5.6

12.3

A02BC05

ATC

esomeprazole; systemic

1.3

12.3

1184

9761

X59

ICD-10 Finland

Exposure to unspecified factor

1.5

12.3

502

3573

TKC20

NOMESCO Finland

Catheterisation of bladder

1.7

12.2

285

1778

GDA10

NOMESCO Finland

Biopsy of lung

12.4

12.1

WD205

NOMESCO Finland

Therapy of methastized malignancy with hormones

4.2

12.1

109

N02AE01

ATC

buprenorphine; parenteral, sublingual, transdermal

1.5

12.0

453

3172

C50.41

ICD-10 Finland

Malignant tumor of the upper outer quadrant of the mammary gland, ductal tumor

2.1

12.0

137

672

R07.3

ICD-10 Finland

Other chest pain

1.6

12.0

289

1818

C34.82

ICD-10 Finland

Malignant overall tumor of bronchial and pulmonary adenocarcinoma

5.7

11.9

E66.2

ICD-10 Finland

Extreme obesity with alveolar hypoventilation

5.6

11.7

A79

ICPC

Malignancy NOS

3.1

11.7

200

Z94.0

ICD-10 Finland

Kidney transplant status

4.1

11.7

112

B03XA01

ATC

erythropoietin; parenteral

3.5

11.7

152

K74.6

ICD-10 Finland

Other and unspecified cirrhosis of liver

3.4

11.7

168

Z95.2

ICD-10 Finland

Presence of prosthetic heart valve

2.3

11.7

102

443

C50.99

ICD-10 Finland

Breast, unspecified

2.8

11.7

269

ZXE50

NOMESCO Finland

More than nine and less than 12 hours

3.0

11.7

227

E0000UV

ATC

1.3

11.6

1084

8876

R03AK07

ATC

formoterol and budesonide; inhalant

1.5

11.6

473

3366

M05BA04

ATC

alendronic acid; oral

1.7

11.6

265

1644

J86.00

ICD-10 Finland

Empyema with broncho-pleural fistula

12.6

11.6

Y83.9

ICD-10 Finland

Surgical procedure, unspecified as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

2.4

11.6

400

JN5DR

NOMESCO Finland

PET-CT of upper body metabolism

3.0

11.5

214

J10.0

ICD-10 Finland

Influenza with pneumonia, seasonal influenza virus identified

3.6

11.5

139

5110A

ICD-9 Finland

Pleurisy, Without mention of effusion or current tuberculosis[PLEURITIS SICCA]

+∞

11.5

ZX012

NOMESCO Finland

Radiotherapy with large shaped fields - isocentric therapy

1.8

11.4

185

1031

GAC43

NOMESCO Finland

Total decortication of pleura

120.3

11.4

N10

ICD-10 Finland

Acute tubulo-interstitial nephritis

1.5

11.3

451

3194

I27.9

ICD-10 Finland

Pulmonary heart disease, unspecified

5.8

11.3

SPAT1216

SPAT

Assessment of functional ability

1.4

11.3

538

3951

N18.5

ICD-10 Finland

Chronic kidney disease, stage 5

8.3

11.3

JAH01

NOMESCO Finland

Laparoscopy

2.2

11.3

112

517

S22.3

ICD-10 Finland

Fracture of rib

1.7

11.3

228

1366

B01AC04

ATC

clopidogrel; oral

1.4

11.2

617

4648

N17.8

ICD-10 Finland

Other acute renal failure

3.4

11.2

153

XGX10

NOMESCO Finland

Intrapleural ultrasonography

25.1

11.1

TGD04

NOMESCO Finland

Needle biopsy of the lungs in bronchoscopy

6.8

11.1

A10AE05

ATC

insulin detemir; parenteral

1.8

11.1

181

1015

L04AD01

ATC

ciclosporin; systemic

3.2

11.0

176

K59.09

ICD-10 Finland

Constipation, unspecified

1.7

11.0

214

1264

I15.1

ICD-10 Finland

Hypertension secondary to other renal disorders

3.9

11.0

114

AA1CD

NOMESCO Finland

Very extensive CT of head and brain

2.6

10.9

287

A10AC01

ATC

insulin (human); parenteral (insulins and analog. for injection, intermediate-acting)

1.6

10.9

271

1720

9051/3-C38.4

ICD-O-3

Fibrous mesothelioma, malignant of pleura, NOS

43.4

10.9

N05CD07

ATC

temazepam; oral

1.4

10.9

481

3478

R70.0

ICD-10 Finland

Elevated erythrocyte sedimentation rate

2.4

10.9

369

L04AA01

ATC

[U] ciclosporin; systemic

3.3

10.8

157

3AC01

NOMESCO Finland

3.7

10.8

126

I27.8

ICD-10 Finland

Other specified pulmonary heart diseases

11.9

10.8

D50.0

ICD-10 Finland

Iron deficiency anaemia secondary to blood loss (chronic)

2.1

10.8

123

602

NK4XE

NOMESCO Finland

Joint ultrasound examination not elsewhere classified

1.9

10.8

161

875

A04

ICPC

Weakness/tiredness general

1.5

10.8

392

2723

SPAT1230

SPAT

Aid fitting and borrowing and monitoring of use

1.4

10.8

552

4103

W19

ICD-10 Finland

Unspecified fall

1.6

10.8

294

1912

QBB10

NOMESCO Finland

Major dressing of wound of skin of trunk

2.2

10.8

108

499

I34.09

ICD-10 Finland

Mitral (valve) insufficiency

1.9

10.7

153

819

Z01.8

ICD-10 Finland

Other specified special examinations

1.4

10.7

612

4641

XX1XW

NOMESCO Finland

Extensive written report from radiologist

2.6

10.7

279

C07AB02

ATC

metoprolol; systemic

1.3

10.6

825

6567

HAC20

NOMESCO Finland

Total mastectomy

2.2

10.6

102

463

I36.1

ICD-10 Finland

Nonrheumatic tricuspid (valve) insufficiency

3.0

10.6

208

SPAT1217

SPAT

Assessment of need for services (elderly/care support)

1.6

10.6

290

1888

N19

ICD-10 Finland

Unspecified kidney failure

1.9

10.5

145

766

R29

ICPC

Respiratory symptom/complaint other

1.8

10.5

166

918

C78.7

ICD-10 Finland

Secondary malignant neoplasm of liver and intrahepatic bile duct

2.4

10.5

367

TNX10

NOMESCO Finland

Arthrocentesis, unspecified region, unspecified region

1.8

10.5

181

1035

C34.9

ICD-10 Finland

Malignant neoplasm: Bronchus or lung, unspecified

3.0

10.5

189

I25.0

ICD-10 Finland

Atherosclerotic cardiovascular disease, so described

1.6

10.5

258

1634

NA3AA

NOMESCO Finland

Lumbar spine X-ray examination without contrast

1.6

10.5

272

1746

I26.0

ICD-10 Finland

Pulmonary embolism with mention of acute cor pulmonale

2.6

10.4

296

E000001

ATC

1.4

10.4

549

4102

WD225

NOMESCO Finland

Demanding therapy of methastized malignancy with hormones

3.5

10.4

131

J92

ICD-10 Finland

Pleural plaque

32.6

10.3

201

Kela drug reimbursment

Chronic cardiac insufficiency

1.6

10.3

236

1467

C83.31

ICD-10 Finland

Diffuse lymphoma with large B cells

3.0

10.3

200

SPAT1144

SPAT

Treatment of reopened or infected surgical wound

1.7

10.3

234

1452

Z95.0

ICD-10 Finland

Presence of electronic cardiac devices

1.7

10.3

212

1276

WB121

NOMESCO Finland

Demanding neoadjuvant cytostatic therapy

4.0

10.3

102

8140/3-C34.3

ICD-O-3

Adenocarcinoma, NOS, of lower lobe, lung

5.7

10.2

J98.4

ICD-10 Finland

Other disorders of lung

23.4

10.2

XF603

NOMESCO Finland

Direct intraarterial blood pressure measurement

2.0

10.2

123

619

TGD00

NOMESCO Finland

Needle biopsy of lung

6.2

10.1

ZXD10

NOMESCO Finland

Scheduled procedure

1.3

10.1

1186

9979

01220

ICD-8 Finland

Other respiratory tuberculosis, Pleurisy with effusion without mention of cause

7.9

10.1

X76

ICPC

Malignant neoplasm breast female

3.2

10.0

156

155

Kela drug reimbursment

Afatinib and gefitinib

14.6

10.0

WX721

NOMESCO Finland

Oxygen concentrator therapy

40.2

10.0

C45.9

ICD-10 Finland

Mesothelioma, unspecified

40.2

10.0

C01DA02

ATC

glyceryl trinitrate; oral, oral aerosol, sublingual, transdermal

1.3

9.9

929

7584

L01BA01

ATC

methotrexate; systemic (folic acid analog.)

2.1

9.9

112

549

R03AC12

ATC

salmeterol; inhalant

1.8

9.9

163

919

RS221

NOMESCO Finland

3.2

9.9

158

191

Kela drug reimbursment

Erlotinib

7.6

9.9

E87.5

ICD-10 Finland

Hyperkalaemia

2.6

9.9

280

JAH00

NOMESCO Finland

Laparotomy

2.2

9.8

448

A41.8

ICD-10 Finland

Other specified sepsis

2.6

9.8

263

NA2AA

NOMESCO Finland

Thoracal spine X-ray examination without contrast

2.4

9.8

337

J10.1

ICD-10 Finland

Influenza with other respiratory manifestations, seasonal influenza virus identified

3.0

9.8

176

E11.5

ICD-10 Finland

Type 2 diabetes mellitus, with peripheral circulatory complications

2.2

9.8

429

I34.1

ICD-10 Finland

Mitral (valve) prolapse

2.2

9.8

441

R28

ICPC

Limited function/disability (R)

3.4

9.7

138

IAZ97

NOMESCO Finland

Psychiatric consultation in another specialty

4.2

9.7

SPAT1149

SPAT

Suture or treatment of traumatic wound

1.4

9.7

413

2960

C03EB01

ATC

furosemide and potassium-sparing agents; systemic

1.7

9.7

190

1130

TPW99

NOMESCO Finland

Other minor surgical procedure on peripheral vessel or lymphatic system

3.3

9.7

139

5188X

ICD-9 Finland

Other diseases of lung

5.8

9.6

PJD42

NOMESCO Finland

Excision of axillary lymph nodes

3.8

9.6

104

KA2AE

NOMESCO Finland

Ultrasound examination transplanted kidney

4.9

9.6

WX402

NOMESCO Finland

General anaesthesia

1.4

9.5

400

2860

I30.9

ICD-10 Finland

Acute pericarditis, unspecified

5.7

9.5

137

Kela drug reimbursment

Uraemia requiring dialysis

3.7

9.5

110

J01MA02

ATC

ciprofloxacin; systemic

1.3

9.5

1307

11198

R06.2

ICD-10 Finland

Wheezing

2.0

9.5

113

566

S22.0

ICD-10 Finland

Fracture of thoracic vertebra

2.6

9.4

257

N05BA06

ATC

lorazepam; systemic, sublingual

1.8

9.4

173

1007

J93.0

ICD-10 Finland

Spontaneous tension pneumothorax

+∞

9.4

E11.9

ICD-10 Finland

Type 2 diabetes mellitus, without complications

1.3

9.4

831

6723

ZXA00

NOMESCO Finland

Right side

1.3

9.4

882

7199

KA2AT

NOMESCO Finland

Biopsy of transplanted kidney with ultrasound guidance

5.8

9.3

4912A

ICD-9 Finland

Chronic bronchitis, Obstructive chronic bronchitis[BRONCHITIS CHRONICA OBSTRUCTIVA]

3.8

9.3

102

HA1AT

NOMESCO Finland

Biopsy of mammary glands with ultrasound guidance

3.0

9.3

180

7931A

ICD-9 Finland

Nonspecific abnormal findings on radiological and other examination of body structure, Lung field

4.3

9.3

NK6AN

NOMESCO Finland

Total body bone isotope imaging

2.0

9.2

110

552

I34.00

ICD-10 Finland

Mitral (valve) incompetence NOS or of specified cause, except rheumatic

2.2

9.2

413

E10.7

ICD-10 Finland

Type 1 diabetes mellitus, With multiple complications

2.5

9.2

273

206

Kela drug reimbursment

Chronic coronary artery disease and dyslipidaemia associated with chronic coronary artery disease

1.3

9.2

836

6786

ZX108

NOMESCO Finland

Inhalation

4.4

9.2

C79.30

ICD-10 Finland

Secondary malignant tumor of the cerebrum

3.4

9.1

124

XW000

NOMESCO Finland

Bone marrow biopsy

1.8

9.1

141

777

R09.1

ICD-10 Finland

Pleurisy

2.9

9.1

184

A02BA02

ATC

ranitidine; systemic

1.3

9.1

658

5170

TQX10

NOMESCO Finland

Biopsy of skin and subcutaneous tissue

1.5

9.1

309

2119

R05

ICD-10 Finland

Cough

1.4

9.1

517

3911

UGC18

NOMESCO Finland

Flexible bronchoscopy with biopsy of lung

5.1

9.1

NH3AA

NOMESCO Finland

Foot and toes X-ray examination

1.6

9.0

207

1289

J86.09

ICD-10 Finland

Pyothorax with fistula

15.6

9.0

C77.1

ICD-10 Finland

Secondary and unspecified malignant neoplasm: Intrathoracic lymph nodes

7.0

9.0

M06.9

ICD-10 Finland

Rheumatoid arthritis, unspecified

2.2

9.0

425

WW200

NOMESCO Finland

Immunization

2.3

9.0

371

SPAT1109

SPAT

Analgesia with portable analgesic pump

3.9

9.0

JN6AD

NOMESCO Finland

CT of torso and neck

3.2

9.0

142

133

Kela drug reimbursment

Severe chronic pancreatic insufficiency

2.9

9.0

180

A02BC01

ATC

omeprazole; systemic

1.3

9.0

891

7316

A16.5

ICD-10 Finland

Tuberculous pleurisy, without mention of bacteriological or histological confirmation

18.6

8.9

C78.8

ICD-10 Finland

Secondary malignant neoplasm of other and unspecified digestive organs

7.4

8.9

YG1AD

NOMESCO Finland

CT examination of thorax for dose design of radiotherapy

2.9

8.9

182

R03AC13

ATC

formoterol; inhalant

1.8

8.9

150

851

B05DA

ATC

Isotonic solutions

4.2

8.8

290

Kela drug reimbursment

Apixaban, dabigatran, edoxaban and rivaroxaban for the treatment of atrial fibrillation

1.4

8.8

539

4120

J43.2

ICD-10 Finland

Centrilobular emphysema

7.9

8.8

RD210

NOMESCO Finland

2.8

8.8

189

Z49.2

ICD-10 Finland

Other dialysis

3.9

8.8

JAL20

NOMESCO Finland

Excision or destruction of lesion of peritoneum

9.5

8.8

I25.5

ICD-10 Finland

Ischaemic cardiomyopathy

2.3

8.8

359

J44

ICD-10 Finland

Other chronic obstructive pulmonary disease

2.3

8.7

333

I31.8

ICD-10 Finland

Other specified diseases of pericardium

14.0

8.7

J98.0

ICD-10 Finland

Diseases of bronchus, not elsewhere classified

50.1

8.7

R03AK08

ATC

formoterol and beclometasone; inhalant

2.1

8.7

432

E11.8

ICD-10 Finland

Type 2 diabetes mellitus, with unspecified complications

1.5

8.7

335

2355

J45.0

ICD-10 Finland

Predominantly allergic asthma

1.7

8.7

182

1107

ZX109

NOMESCO Finland

Instruction on medicine inhalation technique

4.2

8.7

V03AE02

ATC

sevelamer; oral

4.8

8.7

Angiography of the heart and coronary arteries

1.5

8.6

295

2021

NHQ40

NOMESCO Finland

Amputation of toe

2.3

8.6

315

L01XE03

ATC

[U] erlotinib; oral

7.6

8.6

J01DA01

ATC

[U] cefalexin; systemic

1.2

8.6

1921

17305

RJ411

NOMESCO Finland

5.0

8.6

PD4CG

NOMESCO Finland

Extensive MRI examination of abdominal aortta and vasculature of lower extremities with high intensity magnet

2.6

8.6

234

Y83

ICD-10 Finland

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

1.6

8.6

249

1644

FJA10

NOMESCO Finland

Transvenous biopsy of right ventricle

5.5

8.6

R19.0

ICD-10 Finland

Intra-abdominal and pelvic swelling, mass and lump

2.6

8.6

245

PA6DE

NOMESCO Finland

Neck artery ultrasound examination with Doppler method

1.7

8.6

184

1126

20199

ICD-8 Finland

Hodgkin's disease

16.3

8.5

J01XX08

ATC

linezolid; systemic

4.8

8.5

C50.91

ICD-10 Finland

Malignant tumor in another specified localization in ductal mammary gland

3.3

8.5

126

5150X

ICD-9 Finland

Postinflammatory pulmonary fibrosis[FIBROSIS PULMONUM E CAUSA IGNOTA]

10.0

8.5

XF655

NOMESCO Finland

Measurement of heart muscle perfusion with exercise

1.9

8.5

112

583

WX726

NOMESCO Finland

High-flow oxygen therapy

27.6

8.5

Z94.2

ICD-10 Finland

Lung transplant status

27.6

8.5

PG5DE

NOMESCO Finland

Ultrasound examination of injection gate to artery or vein with Doppler method

6.4

8.5

WZB00

NOMESCO Finland

Telephone receipt or other advice

1.3

8.5

650

5145

Z3229

NOMESCO Finland

Other healthcare associate professional

1.5

8.4

268

1806

C34.3

ICD-10 Finland

Malignant neoplasm: Lower lobe, bronchus or lung

2.6

8.4

231

QDB05

NOMESCO Finland

Revision of wound of skin of lower limb

2.1

8.4

424

Z73.3

ICD-10 Finland

Stress, not elsewhere classified

3.8

8.4

NF1AA

NOMESCO Finland

Hip X-ray examination

1.5

8.3

277

1886

M32.9

ICD-10 Finland

Systemic lupus erythematosus, unspecified

4.5

8.3

5120A

ICD-9 Finland

Pneumothorax, Spontaneous tension pneumothorax

+∞

8.3

9053/3-C38.4

ICD-O-3

Mesothelioma, biphasic, malignant of pleura, NOS

+∞

8.3

WD515

NOMESCO Finland

Demanding therapy of malignancy with enzyme inhibitors and similar treatments

6.2

8.3

9680/3-C77.8

ICD-O-3

Diffuse large B-cell lymphoma, NOS, of lymph nodes of multiple regions

10.7

8.3

R77.0

ICD-10 Finland

Abnormality of albumin

9.4

8.3

601

Kela drug reimbursment

Severe malabsorption of nutrients, mainly fats

3.2

8.2

124

H02AB09

ATC

hydrocortisone; systemic

2.4

8.2

284

OAB73

NOMESCO Finland

Prevention and treatment of malnutrition

4.4

8.2

8140/3-C34.1

ICD-O-3

Adenocarcinoma, NOS, of upper lobe, lung

3.9

8.2

P01AB01

ATC

metronidazole; oral, rectal

1.3

8.2

1014

8539

E78.0

ICD-10 Finland

Pure hypercholesterolaemia

0.7

8.1

316

4290

Z25.8

ICD-10 Finland

Need for immunization against other specified single viral diseases

0.6

8.1

115

1906

JBA10

NOMESCO Finland

Transabdominal biopsy or excision of lesion of diaphragm

33.4

8.1

I30.8

ICD-10 Finland

Other forms of acute pericarditis

17.2

8.1

320

Kela drug reimbursment

Lanthanum carbonate, sevelamer and sucroferric oxyhydroxide

4.8

8.0

J01FA15

ATC

telithromycin; oral

1.6

8.0

232

1530

ZZR10

NOMESCO Finland

Flap of skin and muscle

4.3

8.0

W06

ICD-10 Finland

Fall involving bed

3.2

8.0

122

WB123

NOMESCO Finland

Demanding adjuvant cytostatic therapy

3.5

7.9

101

KAS10

NOMESCO Finland

Allogenic transplantation of kidney from cadaver donor

3.8

7.9

ZY020

NOMESCO Finland

Telephone, letter or other consultation without direct patient contact

1.6

7.9

181

1128

R06AE07

ATC

cetirizine; oral

1.2

7.9

1055

8961

ZZA00

NOMESCO Finland

Split skin graft

1.9

7.9

108

574

E13.9

ICD-10 Finland

Other specified diabetes mellitus, without complications

3.4

7.9

107

FWD00

NOMESCO Finland

Reoperation for superficial haemorrhage in surgery of heart and major thoracic vessels

3.4

7.9

107

FNC10

NOMESCO Finland

Aorto-coronary venous bypass with single distal anastomosis

2.4

7.8

252

I27.2

ICD-10 Finland

Other secondary pulmonary hypertension

4.7

7.8

TQW99

NOMESCO Finland

Other minor procedure on skin

1.7

7.8

158

953

I95.9

ICD-10 Finland

Hypotension, unspecified

2.5

7.8

227

KA1AE

NOMESCO Finland

Kidney ultrasound examination

2.1

7.8

391

I48.1

ICD-10 Finland

Persistent atrial fibrillation

2.0

7.8

477

I10

ICD-10 Finland

Essential (primary) hypertension

1.2

7.8

2045

18654

R03AC03

ATC

terbutaline; inhalant

1.4

7.8

341

2460

A12BA01

ATC

potassium chloride; oral

1.6

7.7

195

1243

GDG10

NOMESCO Finland

Bilateral transplantation of lung

45.1

7.7

A15.6

ICD-10 Finland

Tuberculous pleurisy, confirmed bacteriologically and histologically

45.1

7.7

C45.1

ICD-10 Finland

Mesothelioma of peritoneum

45.1

7.7

J01EE02

ATC

sulfadiazine and trimethoprim; systemic

1.3

7.7

730

5948

Z94.1

ICD-10 Finland

Heart transplant status

7.4

7.7

XG460

NOMESCO Finland

Short time oxymetry

2.3

7.6

278

C48.89

ICD-10 Finland

Overall malignant tumor of the peritoneum and retroperitoneum other or unspecified tumor

18.4

7.6

L01XE13

ATC

[U] afatinib; oral

18.4

7.6

E11.00

ICD-10 Finland

Non-insulin dependent diabetes diabetic hypoglycaemic coma

1.8

7.5

133

769

A29

ICPC

General symptom/complaint other

1.4

7.5

327

2355

L98.4

ICD-10 Finland

Chronic ulcer of skin, not elsewhere classified

2.2

7.5

325

F10.25

ICD-10 Finland

Alcohol dependence continuous use

2.8

7.5

168

C34.1

ICD-10 Finland

Malignant neoplasm: Upper lobe, bronchus or lung

2.2

7.5

326

B01AF02

ATC

apixaban; oral

1.4

7.5

332

2402

TFP20

NOMESCO Finland

Cardiodefibrillation

1.5

7.5

265

1831

F10.39

ICD-10 Finland

Withdrawal symptoms caused by alcohol UNS

3.2

7.5

112

A10BH05

ATC

linagliptin; oral

1.6

7.5

168

1041

R03DA04

ATC

theophylline; systemic, rectal

1.6

7.5

212

1394

Z31.5

ICD-10 Finland

Genetic counselling

2.1

7.4

386

QBB05

NOMESCO Finland

Revision of wound of skin of trunk

3.3

7.4

107

T81.3

ICD-10 Finland

Disruption of operation wound, not elsewhere classified

2.2

7.4

341

WX704

NOMESCO Finland

Intubation

1.6

7.4

182

1158

L02BG06

ATC

exemestane; oral

3.2

7.4

113

K56.6

ICD-10 Finland

Other and unspecified intestinal obstruction

1.8

7.4

117

655

JN4JR

NOMESCO Finland

Whole body extensive metabolic PET with CT

3.5

7.4

R05

ICPC

Cough

1.3

7.3

541

4253

A01AB09

ATC

miconazole; local oral

1.5

7.3

245

1675

HAE20

NOMESCO Finland

Reconstruction of areola and mamilla using graft or flap

3.7

7.3

XG405

NOMESCO Finland

Education on PEF monitoring

2.8

7.3

152

351

Kela drug reimbursment

Apixaban, dabigatran, edoxaban and rivaroxaban for the treatment of atrial fibrillation

1.3

7.3

465

3571

WD135

NOMESCO Finland

Demanding cystostatic therapy of methastized malignancy

3.3

7.3

103

JAK10

NOMESCO Finland

Laparotomy and insertion of peritoneal dialysis catheter

4.3

7.3

E10.5

ICD-10 Finland

Type 1 diabetes mellitus, With peripheral circulatory complications

4.3

7.3

SPAT1234

SPAT

Support of social functional capacity

1.6

7.3

170

1066

F10.29

ICD-10 Finland

Addiction caused by alcohol UNS

2.3

7.3

283

ZY010

NOMESCO Finland

Hospital outpatient

2.0

7.3

459

J99.0*M05.1

ICD-10 Finland

Rheumatoid lung disease

+∞

7.3

5111A

ICD-9 Finland

Pleurisy, With effusion, with mention of a bacterial cause other than tuberculosis[PLEURITIS EXSUDATIVA BACTERICA]

+∞

7.3

C25.0

ICD-10 Finland

Malignant neoplasm: Head of pancreas

2.6

7.3

200

R96

ICPC

Asthma

1.5

7.3

219

1460

J45.8

ICD-10 Finland

Mixed asthma

2.0

7.3

434

ZX070

NOMESCO Finland

Intensity modified radiotherapy

2.2

7.2

328

B05DB

ATC

Hypertonic solutions

4.0

7.2

FN1BC

NOMESCO Finland

Extensive angiography of hear and/or coronary arteries

1.6

7.2

199

1303

XW4AT

NOMESCO Finland

Biopsy of other inner organ with ultrasound guidance

5.8

7.2

A09AA02

ATC

multienzymes (lipase, protease etc.)

2.2

7.2

298

5BA08

NOMESCO Finland

4.3

7.2

J05AB11

ATC

valaciclovir; oral

1.4

7.2

320

2316

Z45.0

ICD-10 Finland

Adjustment and management of cardiac devices

1.7

7.2

156

961

Z03.9

ICD-10 Finland

Observation for suspected disease or condition, unspecified

1.3

7.2

478

3701

GDC01

NOMESCO Finland

Thoracoscopic lobectomy of lung

3.5

7.2

WW200

SPAT

0.6

7.2

1560

103

Kela drug reimbursment

Diabetes, insulin-treated

1.2

7.1

916

7729

GA2CT

NOMESCO Finland

Pleural biopsy with CT guidance

20.0

7.1

M01AE03

ATC

ketoprofen; systemic, rectal

1.2

7.1

1163

10079

JN3CD

NOMESCO Finland

Abdominal CT examination both without and with contrast

1.8

7.1

122

701

NGQ20

NOMESCO Finland

Amputation of lower leg

3.5

7.1

EBA10

NOMESCO Finland

Surgical removal of tooth

1.5

7.1

221

1487

ZXA05

NOMESCO Finland

Left side

1.3

7.0

805

6702

N05AH04

ATC

quetiapine; oral

1.4

7.0

371

2767

R2130

NOMESCO Finland

Counselling and guidance which enhance independent living

1.5

7.0

228

1550

196

Kela drug reimbursment

Paricalcitol and cinacalcet

4.7

7.0

Z94.4

ICD-10 Finland

Liver transplant status

7.0

AA1

Conventional CABG

2.0

7.0

455

Z72.0

ICD-10 Finland

Tobacco use

2.3

7.0

245

D38.3

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Mediastinum

4.9

7.0

ZX112

NOMESCO Finland

Subcutaneous

2.1

6.9

344

S42.0

ICD-10 Finland

Fracture of clavicle

2.1

6.9

370

R04.0

ICD-10 Finland

Epistaxis

1.5

6.9

241

1661

K92.0

ICD-10 Finland

Haematemesis

1.9

6.9

476

E86

ICD-10 Finland

Volume depletion

2.0

6.9

451

D07AC01

ATC

betamethasone; topical

1.2

6.8

960

8184

H3603, E103

ICD-10 Finland

3.5

6.8

WX250

NOMESCO Finland

Intercostal blockade

6.1

6.8

GDA96

NOMESCO Finland

Other incision, excision of lesion or repair of lung

40.1

6.8

R03AL02

ATC

salbutamol and ipratropium bromide; inhalant

2.9

6.7

127

A10AB01

ATC

insulin (human); parenteral (insulins and analog. for injection, fast-acting)

1.9

6.7

491

HAE10

NOMESCO Finland

Reconstruction of breast using graft or flap

3.4

6.7

C57.0

ICD-10 Finland

Malignant neoplasm: Fallopian tube

7.2

6.7

S81.8

ICD-10 Finland

Open wound of other parts of lower leg

1.9

6.7

492

F20.9

ICD-10 Finland

Schizophrenia, unspecified

2.6

6.7

168

F17.29

ICD-10 Finland

Addiction caused by tobacco UNS

2.7

6.7

151

C50.90

ICD-10 Finland

Malignant tumor in other or unspecified location in mammary gland without histology

2.8

6.7

138

JN6BD

NOMESCO Finland

Extensive CT of torso and neck

3.2

6.7

100

T36

ICD-10 Finland

Poisoning by systemic antibiotics

2.0

6.7

425

3004

Kela drug reimbursment

Osimertinib

22.5

6.7

1519

Kela drug reimbursment

22.5

6.7

ZXD30

NOMESCO Finland

Difficulties in perfomrming procedure

1.7

6.7

122

717

N08.39

ICD-10 Finland

Glomerular disorders in diabetes mellitus microalbuminuria

3.6

6.7

Z03.5

ICD-10 Finland

Observation for other suspected cardiovascular diseases

1.5

6.6

194

1290

313

Kela drug reimbursment

Abatacept, adalimumab, anakinra, certolizumab pegol, etanercept, golimumab, infliximab, ixekizumab, sarilumab, secukinumab, tocilizumab and ustekinumab (rheumatoid diseases)

2.3

6.6

232

X77

ICPC

Malignant neopl genital female other

7.8

6.6

4019X

ICD-9 Finland

Essential hypertension, Unspecified

1.7

6.6

138

839

I97.0

ICD-10 Finland

Postcardiotomy syndrome

4.2

6.6

E10.2

ICD-10 Finland

Type 1 diabetes mellitus, With renal complications

3.5

6.6

R85

ICPC

Malignant neopl respiratory other

8.7

6.5

YN7BD

NOMESCO Finland

Extensive CT examination of spine for dose design of radiotherapy

4.8

6.5

8441/3-C56.9

ICD-O-3

Serous carcinoma, NOS, of ovary

6.8

6.5

S18

ICPC

Laceration/cut

1.2

6.5

1248

10971

WYA30

NOMESCO Finland

Preparations for expected poor cooperation

1.5

6.5

195

1302

R03BB07

ATC

umeclidinium bromide; inhalant

3.5

6.5

N06AB04

ATC

citalopram; systemic

1.3

6.5

562

4517

I85.9

ICD-10 Finland

Oesophageal varices without bleeding

2.9

6.4

120

156

Kela drug reimbursment

Lapatinib

69.9

6.4

GDD20

NOMESCO Finland

Extended pneumonectomy

69.9

6.4

Y69

ICD-10 Finland

Unspecified misadventure during surgical and medical care

2.7

6.4

143

E11.6

ICD-10 Finland

Type 2 diabetes mellitus, with other specified complications

2.1

6.4

316

ZXM10

NOMESCO Finland

Intraoperative use of conventional X-ray imaging

1.6

6.4

140

866

1502

Kela drug reimbursment

Cabozantinib

7.4

6.4

GDB10

NOMESCO Finland

Wedge resection of lung

7.4

6.4

WC125

NOMESCO Finland

Demanding cytostatic therapy of local tumor recidive

7.4

6.4

E16.2

ICD-10 Finland

Hypoglycaemia, unspecified

2.6

6.4

177

R2110

NOMESCO Finland

Giving the first information

1.6

6.4

149

936

R03AC18

ATC

indacaterol; inhalant

3.3

6.3

J43.9

ICD-10 Finland

Emphysema, unspecified

2.3

6.3

235

I35.1

ICD-10 Finland

Aortic (valve) insufficiency

1.6

6.3

172

1123

A41.1

ICD-10 Finland

Sepsis due to other specified staphylococcus

3.4

6.3

E11.2

ICD-10 Finland

Type 2 diabetes mellitus, with renal complications

1.7

6.3

125

750

ZST00

NOMESCO Finland

Procedure related to previous procedure classified in chapter T

5.9

6.3

5100A

ICD-9 Finland

Empyema, With fistula

11.0

6.3

NF3AA

NOMESCO Finland

Femur X-ray examination

2.1

6.3

312

J12.9

ICD-10 Finland

Viral pneumonia, unspecified

4.6

6.3

4939X

ICD-9 Finland

Asthma, unspecified[ASTHMA BRONCHIALE NUD]

2.4

6.3

218

C64.88

ICD-10 Finland

Other malignant neoplasm of kidney, except renal pelvis

1.9

6.3

430

GDD96

NOMESCO Finland

Other pneumonectomy

+∞

6.2

51299

ICD-8 Finland

Spontaneous pneumothorax

+∞

6.2

J98.5

ICD-10 Finland

Diseases of mediastinum, not elsewhere classified

+∞

6.2

N06AX16

ATC

venlafaxine; oral

1.4

6.2

251

1782

SPAT1301

SPAT

No procedures

1.2

6.2

949

8143

L17

ICPC

Foot/toe symptom/complaint

1.3

6.2

664

5472

SPAT1256

SPAT

Intramuscular and subcutaneous injection

1.2

6.2

1248

11001

C574, 8461, 3

ICD-O-3

26.7

6.2

GAW97

NOMESCO Finland

Other thoracoscopic operation on chest wall, pleura and diaphragm

26.7

6.2

C25.9

ICD-10 Finland

Malignant neoplasm: Pancreas, unspecified

2.6

6.2

157

SPAT1260

SPAT

Consultation of another employee

1.3

6.2

490

3886

C50.80

ICD-10 Finland

Overall malignant tumor of the mammary gland, no histological veryfication

7.0

6.2

E85.9

ICD-10 Finland

Amyloidosis, unspecified

7.0

6.2

M86.9

ICD-10 Finland

Osteomyelitis, unspecified

2.9

6.2

127

D07AB02

ATC

hydrocortisone butyrate; topical

1.2

6.2

743

6209

WB401

NOMESCO Finland

Simple antibody therapy of primary tumour

3.5

6.2

4931A

ICD-9 Finland

Asthma, Intrinsic asthma[INTRINSIC ASTHMA SINE EXACERBATIONE]

2.8

6.2

128

JA3BT

NOMESCO Finland

Cathetrisation of abdominal cavity with X-ray guidance

6.3

6.2

NH2AA

NOMESCO Finland

Heel X-ray examination

4.5

6.1

XX1AW

NOMESCO Finland

Written report from X-ray examination without contrast peformed elsewhere

5.3

6.1

ZX121

NOMESCO Finland

Central venous catheter

5.7

6.1

AA1CG

NOMESCO Finland

Extensive MRI examination of brain with high intensity magnet

1.5

6.1

176

1165

F10.20

ICD-10 Finland

Alcohol dependence currently independent

2.3

6.1

234

WX204

NOMESCO Finland

Axillary plexus blockaced

2.0

6.1

386

K99

ICPC

Cardiovascular disease other

1.8

6.1

532

C08DA01

ATC

verapamil; systemic

1.6

6.1

130

799

SPAT1220

SPAT

Assessment of need for rehabilitation and/or rehabilitation plan

1.5

6.1

186

1247

A07AA02

ATC

nystatin; oral

1.5

6.1

177

1174

ZXE11

NOMESCO Finland

Procedure duration 60 to 89 minutes

1.7

6.1

116

688

J40

ICD-10 Finland

Bronchitis, not specified as acute or chronic

2.0

6.1

363

R10.1

ICD-10 Finland

Pain localized to upper abdomen

1.3

6.1

378

2895

GD2SN

NOMESCO Finland

Lung ventilation SPECT

3.6

6.1

R94.2

ICD-10 Finland

Abnormal results of pulmonary function studies

3.6

6.1

A40.8

ICD-10 Finland

Other streptococcal sepsis

2.8

6.1

130

R03AK04

ATC

salbutamol and sodium cromoglicate; inhalant

2.9

6.0

114

YX9AD

NOMESCO Finland

Other CT eamination for dose design of radiotherapy

2.0

6.0

339

K44.9

ICD-10 Finland

Diaphragmatic hernia without obstruction or gangrene

1.5

6.0

209

1444

QX2XE

NOMESCO Finland

Ultrsound examination of soft tissue not elsewhere classified

2.0

6.0

380

F10.9

ICD-10 Finland

Mental and behavioural disorders due to use of alcohol, Unspecified mental and behavioural disorder

3.0

6.0

103

RS222

NOMESCO Finland

2.5

6.0

180

LabWAS

↥

(ID) Name

N Cases

N Controls

-log₁₀(p)

cases

controls

unit

cases

controls

-log₁₀(p)

N cases

N controls

(3023199) Leukocytes [#/volume] in Pleural fluid

1004

284

46.56

307.65

1.8

1.2

e6/l

2063.2

1792.8

0.23

829

193

(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction

1300

4132

4.15

307.65

3.9

u/l

243.7

246.5

0.26

1254

3858

(40768806) Pleura Pathology biopsy report

902

203

56.76

307.65

1.9

1.2

—

(3035880) pH of Pleural fluid

507

108

53.46

307.65

1.4

1.2

—

(3052649) Adenosine deaminase [Enzymatic activity/volume] in Serum or Plasma

605

117

60.54

307.65

1.6

1.3

u/l

12.6

14.1

1.16

584

109

(3020630) Protein [Mass/volume] in Serum or Plasma

1217

2942

5.47

307.65

2.7

2.5

g/l

63.3

66.2

26.07

1154

2617

(3023383) Lactate [Moles/volume] in Pleural fluid

313

65.11

307.65

1.5

1.3

mmol/l

3.7

2.9

1.46

289

(3000919) Neutrophils/100 leukocytes in Pleural fluid

242

41.43

307.65

1.5

1.2

18.5

30.5

2.19

222

(3001893) Eosinophils/100 leukocytes in Pleural fluid

281

47.08

307.65

1.6

1.3

3.5

3.1

0.08

238

(3005702) Mycobacterium sp identified in Specimen by Organism specific culture

711

573

14.82

307.65

1.9

1.3

—

(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection

865

1035

10.34

307.65

2.6

—

(3045788) Cell count panel - Pleural fluid

732

231

38.40

307.65

1.9

1.3

—

(3036428) Adenosine deaminase [Enzymatic activity/volume] in Pleural fluid

709

109

78.52

307.65

1.4

1.2

u/l

13.5

14.4

0.13

671

(36305247) Microscopic observation [Identifier] in Isolate by Gram stain

638

866

8.55

307.65

1.8

1.7

—

(3003434) Protein [Mass/volume] in Pleural fluid

1152

304

52.41

307.65

1.8

1.2

g/l

35.4

27.5

19.22

1081

258

(3009804) Carcinoembryonic Ag [Mass/volume] in Pleural fluid

281

79.34

307.65

1.4

1.1

ug/l

480.0

908.0

0.23

154

(3005532) Lymphocytes/100 leukocytes in Pleural fluid

314

38.57

307.65

1.6

1.2

63.5

61.1

0.23

265

(3028308) Erythrocytes [#/volume] in Pleural fluid

925

256

46.43

307.65

1.8

1.2

e6/l

69646.1

21786.7

4.07

640

144

(3042936) Bacteria identified in Isolate by Culture

1562

4477

5.03

307.65

2.6

2.0

—

(3036782) Glucose [Moles/volume] in Pleural fluid

775

193

49.34

307.65

1.5

1.2

mmol/l

5.9

7.1

4.34

721

184

(40763082) Lactate dehydrogenase [Enzymatic activity/volume] in Pleural fluid by Lactate to pyruvate reaction

832

181

57.49

307.65

1.5

1.2

u/l

410.1

329.8

0.80

801

171

(3012441) Differential panel - Pleural fluid

865

220

49.63

307.65

1.9

1.2

—

(3026051) Polymorphonuclear cells/100 leukocytes in Pleural fluid

250

52.15

307.65

1.6

1.2

22.3

23.1

0.08

219

(3023368) Bacteria identified in Blood by Culture

2070

10223

3.08

268.40

6.3

4.2

—

(3041918) Cholesterol [Moles/volume] in Pleural fluid

158

41.05

261.02

1.4

1.2

mmol/l

1.8

1.2

1.07

137

(44786800) Granulocytes/100 leukocytes in Body fluid

138

67.98

252.71

1.4

1.3

21.6

13.8

0.88

108

(3042010) Triglyceride [Moles/volume] in Pleural fluid

145

48.46

249.11

1.4

1.2

mmol/l

1.5

3.7

0.39

123

(3028029) Mesothelial cells/100 leukocytes in Pleural fluid

140

45.27

236.89

1.6

1.2

11.5

5.3

—

(3015401) Amylase [Enzymatic activity/volume] in Pleural fluid

132

54.53

232.40

1.4

1.3

u/l

64.7

2035.6

0.53

113

(3042631) Mycobacterium sp identified in Specimen

306

402

8.15

220.85

2.4

2.6

—

(3014891) Appearance of Pleural fluid

116

38.49

188.64

1.9

1.4

—

(3012095) Magnesium [Moles/volume] in Serum or Plasma

1225

5338

2.85

186.42

5.2

3.0

mmol/l

0.8

3.01

1167

4921

(3032080) INR in Blood by Coagulation assay

2402

14646

2.56

181.83

16.0

10.8

inr

1.4

0.21

647

3905

(42870588) Differential panel, method unspecified - Blood

1878

10474

2.47

168.66

8.1

5.4

—

(3040491) Angiotensin converting enzyme [Enzymatic activity/volume] in Pleural fluid

67.21

168.05

1.1

u/l

20.1

17.0

—

(3019069) Monocytes/100 leukocytes in Blood

2298

14136

2.43

164.39

9.0

6.0

9.4

9.0

7.03

2198

13027

(3022096) Basophils/100 leukocytes in Blood

2244

13682

2.42

163.44

8.7

5.6

0.6

4.94

2143

12587

(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma

2585

16811

2.47

162.43

11.3

6.0

umol/l

11.6

12.6

3.48

2483

15906

(3006504) Eosinophils/100 leukocytes in Blood

2280

14073

2.41

160.44

8.6

5.6

2.5

2.9

12.29

2178

12925

(3002030) Lymphocytes/100 leukocytes in Blood

2315

14417

2.40

159.14

8.8

5.8

21.4

26.2

74.88

2209

13196

(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma

904

3635

2.91

156.70

3.4

4.1

ug/l

29.4

21.9

0.31

741

3030

(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection

1242

5893

2.59

155.43

2.4

1.8

—

(3001604) Monocytes [#/volume] in Blood

2354

14926

2.36

152.95

8.2

5.4

e9/l

0.7

0.6

15.70

2109

12605

(3006315) Basophils [#/volume] in Blood

2364

15023

2.36

152.71

8.3

5.4

e9/l

0.0

1.51

2115

12704

(3013115) Eosinophils [#/volume] in Blood

2413

15505

2.36

151.39

8.6

5.6

e9/l

0.2

2.18

2166

13304

(3019198) Lymphocytes [#/volume] in Blood

2382

15298

2.34

148.50

8.4

5.5

e9/l

1.6

1.9

7.48

2152

13159

(3018010) Neutrophils/100 leukocytes in Blood

2252

14200

2.31

145.56

8.4

5.6

62.6

58.4

47.01

2146

13086

(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay

475

1343

3.87

145.54

3.8

2.6

u/ml

0.3

0.38

291

759

(3013650) Neutrophils [#/volume] in Blood by Automated count

2605

17559

2.34

142.31

16.7

8.4

e9/l

4.6

4.3

5.98

2365

15120

(3018677) aPTT in Platelet poor plasma by Coagulation assay

1148

5442

2.54

142.05

2.9

1.9

30.7

30.1

2.28

1119

5271

(3024561) Albumin [Mass/volume] in Serum or Plasma

2280

14601

2.27

139.92

8.1

4.8

g/l

31.2

34.7

123.38

2141

13425

(3020779) Urea [Moles/volume] in Serum or Plasma

815

3312

2.83

136.81

11.2

6.4

mmol/l

12.5

11.2

4.14

771

3111

(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing

294

615

5.07

132.67

1.5

1.6

—

(3003458) Phosphate [Moles/volume] in Serum or Plasma

999

4574

2.57

131.72

9.2

5.5

mmol/l

1.1

1.0

8.88

945

4179

(3046279) Procalcitonin [Mass/volume] in Serum or Plasma

487

1538

3.46

125.74

2.2

1.8

ug/l

4.8

2.5

0.36

443

1327

(3014111) Lactate [Moles/volume] in Serum or Plasma

762

3133

2.76

124.08

7.2

6.2

mmol/l

1.3

1.4

1.16

719

2995

(3028531) Enolase.neuron specific [Mass/volume] in Serum or Plasma

231

415

5.84

123.24

1.5

2.0

ug/l

24.1

25.0

0.07

225

406

(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma

1855

11338

2.17

122.54

4.7

3.0

ng/l

2855.4

1830.0

7.39

1693

9780

(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma

2292

15274

2.14

120.04

10.9

5.8

mmol/l

1.2

12.46

2128

13657

(4035726)

683

2698

2.84

119.74

1.5

1.3

—

(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma

2463

16882

2.16

119.73

12.7

6.6

mmol/l

1.2

14.17

2057

14152

(3003396) Base excess in Arterial blood by calculation

895

4078

2.53

117.76

8.4

6.5

mmol/l

1.7

0.9

7.86

719

3079

(3027801) Oxygen [Partial pressure] in Arterial blood

892

4089

2.51

115.65

8.4

6.4

kpa

11.1

12.1

7.78

853

3863

(3027946) Carbon dioxide [Partial pressure] in Arterial blood

892

4089

2.51

115.65

8.4

6.5

kpa

5.2

5.0

7.16

849

3861

(3019060) Gas panel - Arterial blood

583

2278

2.82

103.40

5.7

4.4

—

(40763571) Iron/Transferrin [Ratio] in Serum or Plasma

973

4858

2.32

102.80

3.8

2.5

20.0

22.3

5.02

832

4094

(3004789) Transferrin [Mass/volume] in Serum or Plasma

1015

5165

2.28

102.47

3.7

2.5

g/l

2.1

2.3

13.11

945

4746

(3042552) Rheumatoid factor [Units/volume] in Pleural fluid

53.47

101.51

1.1

iu/ml

18.3

—

(3022948) Iron [Moles/volume] in Serum or Plasma

1066

5555

2.24

101.48

3.7

2.5

umol/l

10.2

12.5

22.43

986

5103

(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection

287

738

4.11

99.46

1.8

1.4

—

(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma

1638

10121

2.03

99.28

3.5

2.5

u/l

59.3

0.01

1532

9286

(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection

851

4068

2.38

99.01

2.3

1.7

—

(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection

278

702

4.18

98.72

1.9

1.4

—

(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection

852

4081

2.37

98.63

2.2

1.7

—

(3000620) Complement C3 [Mass/volume] in Serum or Plasma

283

727

4.11

98.19

2.1

1.4

g/l

1.1

1.2

5.27

272

685

(3037522) Nuclear Ab [Titer] in Serum

733

3305

2.48

96.89

1.5

1.3

titre

505.0

508.6

0.02

200

727

(3017766) Complement C4 [Mass/volume] in Serum or Plasma

275

699

4.15

96.77

1.9

1.4

g/l

0.2

0.13

265

660

(3009343) pH of Capillary blood

557

2216

2.75

95.00

6.2

3.3

7.4

0.49

248

(3023024) Carbon dioxide [Partial pressure] in Capillary blood

561

2249

2.73

94.23

6.2

3.3

kpa

5.4

5.1

10.24

532

2038

(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation

542

2136

2.77

94.10

6.1

3.2

mmol/l

2.7

1.5

9.75

444

1495

(3016502) Oxygen saturation in Arterial blood

783

3693

2.39

93.40

8.9

6.7

94.6

95.5

3.09

761

3537

(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection

231

533

4.53

92.15

1.9

1.4

—

(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain

192

380

5.25

91.95

1.2

1.1

—

(3009445) Proteinase 3 Ab [Units/volume] in Serum

388

1287

3.23

91.57

1.3

1.4

u/ml

6.1

13.3

—

(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection

590

2508

2.58

87.74

1.9

1.6

—

(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection

216

500

4.51

85.76

1.6

1.4

—

(1616796) Gas panel - Central venous blood

262

705

3.90

85.07

5.3

3.2

—

(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma

717

3381

2.36

84.87

4.0

2.9

ng/l

381.9

248.7

4.67

675

3100

(3018418) pH of Serum or Plasma

1565

9927

1.94

84.42

7.3

3.9

7.4

0.15

363

1813

(3012501) Base excess in Blood by calculation

257

688

3.92

84.04

6.0

3.6

mmol/l

3.1

2.4

2.84

200

440

(3000991) Gas panel - Venous blood

651

2973

2.42

82.68

10.6

7.5

—

(3005719) IgG [Mass/volume] in Serum or Plasma

507

2058

2.67

82.55

2.9

2.6

g/l

10.7

10.6

0.20

467

1862

(3002032) Base excess in Venous blood by calculation

724

3471

2.32

82.26

6.3

3.7

mmol/l

2.1

1.7

1.79

596

2722

(3021447) Carbon dioxide [Partial pressure] in Venous blood

721

3482

2.30

80.37

6.3

3.6

kpa

6.0

5.8

7.36

687

3354

(3010421) pH of Blood

279

819

3.58

79.69

6.1

3.5

7.4

0.10

254

674

(3036481) Cortisol [Moles/volume] in Serum or Plasma

570

2493

2.50

79.36

2.7

2.2

nmol/l

396.3

376.8

0.92

531

2256

(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection

508

2105

2.61

79.19

1.7

1.5

—

(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection

181

389

4.82

78.69

1.5

1.4

—

(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection

184

406

4.70

77.48

1.7

1.3

—

(46235355) HIV 1 and 2 tests - Meaningful Use set

642

3039

2.32

74.58

1.8

1.6

—

(3013742) Prealbumin [Mass/volume] in Serum or Plasma

651

3114

2.30

73.73

2.5

2.1

g/l

0.2

16.05

595

2871

(3013826) Glucose [Moles/volume] in Serum or Plasma

2555

19441

1.84

73.49

8.4

4.7

mmol/l

6.9

0.28

2479

18271

(3022313) Gas panel - Capillary blood

413

1601

2.76

73.24

6.5

3.4

—

(3028026) IgM [Mass/volume] in Serum or Plasma

416

1620

2.75

73.13

2.1

1.8

g/l

1.3

1.4

0.52

380

1452

(3017181) Myelocytes/100 leukocytes in Blood

575

2617

2.39

72.99

5.1

3.8

1.1

0.9

1.00

259

774

(3002173) Hemoglobin [Mass/volume] in Arterial blood

686

3377

2.24

72.42

9.9

7.2

g/l

116.3

120.2

5.20

670

3245

(3007628) Bicarbonate [Moles/volume] standard in Venous blood

428

1718

2.67

70.81

6.0

3.9

mmol/l

24.2

23.9

1.42

391

1512

(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma

1440

9299

1.85

70.37

5.0

3.2

u/l

41.4

38.6

0.32

1362

8790

(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection

186

451

4.27

69.46

1.5

1.4

—

(3026782) Osmolality of Urine

1148

6963

1.90

67.85

3.7

2.9

mosm/kgh2o

532.9

560.1

4.93

1018

5903

(3049804) Myeloperoxidase IgG Ab [Units/volume] in Serum

263

825

3.34

67.58

1.4

iu/ml

8.5

14.5

—

(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection

177

427

4.29

66.53

1.9

1.4

—

(3002179) Metamyelocytes/100 leukocytes in Blood

516

2352

2.37

64.86

4.6

3.7

0.7

0.6

0.07

190

532

(3012110) Lysozyme [Mass/volume] in Serum or Plasma

226

664

3.54

64.30

1.5

1.9

mg/l

10.6

12.7

1.40

210

603

(3027544) Mycobacterium sp identified in Sputum by Organism specific culture

152

335

4.67

64.04

3.4

3.5

—

(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma

1389

9075

1.80

63.93

2.9

2.2

mg/l

3.5

3.0

6.46

1199

7632

(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma

2989

24336

1.85

63.87

14.9

7.4

u/l

89.8

81.2

16.36

2878

22710

(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma

1868

13323

1.74

63.21

6.0

4.0

ng/l

47.1

106.8

1.10

1574

10240

(3014576) Chloride [Moles/volume] in Serum or Plasma

823

4558

2.01

62.97

10.3

6.2

mmol/l

103.1

104.5

10.78

802

4443

(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma

1060

6396

1.89

62.89

2.0

1.6

mg/l

1.8

1.5

1.69

873

4963

(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma

311

1122

2.92

62.85

1.6

1.7

u/l

35.2

38.3

1.84

265

950

(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

201

556

3.75

62.54

6.3

4.6

iu/ml

198.0

3135.9

0.55

(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence

291

1017

3.00

62.24

1.5

titre

446.2

244.6

0.46

(3021440) Promyelocytes/100 leukocytes in Blood

527

2476

2.30

61.58

5.2

3.8

0.1

0.12

238

712

(3000494) Fungus identified in Specimen by Culture

660

3401

2.12

61.28

1.7

1.4

—

(3044640) Blood type and Crossmatch panel - Blood

1521

10314

1.76

60.92

3.8

2.6

—

(3008152) Bicarbonate [Moles/volume] in Arterial blood

496

2286

2.33

60.57

9.5

6.1

mmol/l

25.2

24.2

6.41

474

2124

(3027945) Reticulocytes/100 erythrocytes in Blood

814

4549

1.99

60.43

2.8

2.4

1.9

1.7

3.51

720

3955

(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma

1109

6883

1.84

59.67

5.8

4.0

ng/l

439.5

585.9

0.38

988

5908

(3023419) Bacteria identified in Sputum by Culture

154

363

4.37

59.63

2.0

2.4

—

(3033658) Prothrombin time (PT) actual/Normal

1255

8089

1.80

59.58

8.5

3.9

80.0

83.8

5.48

1228

7888

(3004490) Bicarbonate [Moles/volume] standard in Capillary blood

347

1375

2.67

58.56

7.4

3.7

mmol/l

25.7

24.5

8.74

329

1236

(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection

113

212

5.45

57.34

1.8

1.4

—

(3017143) Hepatitis C virus Ab [Presence] in Serum

512

2453

2.24

56.85

1.8

1.5

—

(3007853) Bacteria identified in Skin by Aerobe culture

693

3734

2.03

56.70

2.2

1.8

—

(3014218) Bicarbonate [Moles/volume] standard in Arterial blood

419

1846

2.42

56.52

9.8

8.4

mmol/l

24.9

24.1

4.79

379

1690

(40767503) Oxygen content in Capillary blood by calculation

223

718

3.23

54.79

3.3

2.2

14.9

16.1

3.65

107

369

(3005715) Vancomycin [Mass/volume] in Serum or Plasma

168

451

3.84

54.54

6.2

6.4

mg/l

12.3

12.2

0.15

156

411

(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection

142

338

4.32

54.29

2.0

1.4

—

(3025159) Blasts/100 leukocytes in Blood

482

2298

2.24

54.02

5.1

3.8

0.1

0.3

0.87

202

586

(40758558) Short blood count panel - Blood

1187

7733

1.75

53.15

12.8

6.3

—

(3037551) Cancer Ag 125 [Units/volume] in Serum or Plasma

273

1004

2.84

53.10

10.7

3.5

u/ml

303.2

59.5

2.87

267

969

(3024354) Oxygen [Partial pressure] in Venous blood

564

2884

2.11

52.90

5.4

3.1

kpa

4.7

4.5

0.96

536

2769

(3019284) Hepatitis B virus surface Ag [Presence] in Serum

531

2655

2.15

52.79

1.8

1.5

—

(3004588) Protein electrophoresis panel - Serum or Plasma

521

2605

2.15

51.74

2.6

2.3

—

(40760892) CBC W Ordered Manual Differential panel - Blood

969

6014

1.80

50.89

6.8

4.4

—

(3000850) Epithelial cells [#/volume] in Urine

1138

7409

1.74

50.63

3.4

2.7

e6/l

5.2

4.5

0.75

1036

6491

(3012336) Haptoglobin [Mass/volume] in Serum or Plasma

411

1894

2.30

49.80

1.9

1.7

g/l

1.7

1.5

1.79

356

1601

(3021879) Hepatitis B virus core Ab [Presence] in Serum

355

1534

2.44

49.78

1.4

1.3

—

(3002582) Erythrocytes [#/volume] in Urine

1496

10531

1.66

49.54

4.5

3.4

e6/l

55.9

102.3

1.84

1247

8224

(3033799) Differential panel - Peritoneal fluid

7.56

49.19

1.9

2.1

—

(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection

125

295

4.34

48.32

1.7

1.4

—

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

1948

14711

1.62

48.30

6.1

4.2

—

(3031040) Bacteria [#/volume] in Urine by Automated count

2603

21160

1.64

47.22

5.9

4.8

e6/l

149.5

1821.0

3.48

383

(40762366) Oxygen capacity [Volume Fraction] in Arterial blood

406

1902

2.26

47.22

10.7

9.1

—

(3015377) Calcium [Moles/volume] in Serum or Plasma

1558

11184

1.64

47.14

5.8

3.3

mmol/l

2.3

8.99

1381

9547

(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma

640

3564

1.94

46.92

3.5

2.8

umol/l

10.5

9.7

0.32

553

3119

(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay

223

786

2.94

46.82

1.4

1.3

—

(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay

223

786

2.94

46.82

1.4

1.3

—

(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection

128

317

4.14

46.44

1.7

1.4

—

(46236098) ABO and Rh group [Type] in Blood by Confirmatory method

1179

7909

1.69

46.26

3.5

2.5

—

(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay

231

836

2.87

46.21

3.0

2.4

g/l

3.6

0.13

221

788

(3023487) Leukocytes [#/volume] in Peritoneal fluid

111

6.68

45.86

1.8

2.4

e6/l

6780.6

7036.0

0.01

(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection

274

1096

2.61

45.15

1.4

1.3

—

(3030467) Casts [#/volume] in Urine by Automated count

1361

9526

1.64

45.06

4.4

3.3

e6/l

0.6

0.5

1.59

1126

7288

(36304419) Bacteria [Presence] in Urine

1316

9140

1.65

44.89

4.2

3.3

—

(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood

209

732

2.96

44.37

1.6

iu/ml

17.6

19.2

0.03

171

(3043849) Epstein Barr virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

152

439

3.56

44.32

3.2

2.5

u/ml

38890.4

2065.9

0.46

(3028192) IgG subclass 2 [Mass/volume] in Serum

204

4.90

44.22

1.5

1.3

g/l

2.9

3.2

0.63

148

(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method

114

269

4.33

44.08

1.3

—

(3023520) Reticulocytes [#/volume] in Blood

609

3417

1.92

43.41

2.7

2.5

e9/l

69.7

67.6

0.64

467

2636

(3027135) IgG subclass 1 [Mass/volume] in Serum

204

4.85

43.25

1.5

1.3

g/l

7.1

6.9

0.11

149

(3024139) IgG subclass 3 [Mass/volume] in Serum

204

4.85

43.25

1.5

1.3

g/l

0.5

0.05

148

(3023183) Ammonium ion [Moles/volume] in Plasma

206

726

2.94

43.24

3.6

2.6

umol/l

32.6

35.2

0.66

170

598

(3004809) Band form neutrophils/100 leukocytes in Blood

177

574

3.18

42.92

4.4

3.3

1.4

1.6

0.31

149

418

(3006217) Methemoglobin/Hemoglobin.total in Arterial blood

445

2243

2.10

42.89

11.8

7.9

0.6

0.7

0.94

439

2224

(3022217) INR in Platelet poor plasma by Coagulation assay

870

5469

1.75

42.74

33.7

29.8

inr

1.6

1.5

1.34

100

766

(3028653) Carboxyhemoglobin/Hemoglobin.total in Arterial blood

446

2254

2.10

42.68

11.6

7.7

1.5

1.3

3.03

441

2237

(4062490)

207

4.78

42.51

1.5

1.3

—

(3024980) IgG subclass 4 [Mass/volume] in Serum

131

353

3.80

42.30

1.7

1.6

g/l

0.9

0.12

279

(3018095) Leukocytes [#/volume] in Urine

1607

11858

1.59

42.00

5.2

3.9

e6/l

146.8

115.3

0.37

1291

8740

(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma

492

2598

2.02

41.73

5.6

3.8

ng/l

128.3

97.6

5.72

430

2219

(3009613) Erythrocytes [#/volume] in Peritoneal fluid

6.79

41.56

1.8

2.2

e6/l

7580.2

23227.1

0.41

(3037756) Immunofixation for Serum or Plasma

218

825

2.74

40.04

1.5

1.6

—

(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection

194

4.77

39.93

1.7

1.4

—

(3006588) Cancer Ag 15-3 [Units/volume] in Serum or Plasma

131

369

3.63

39.66

6.4

3.7

u/ml

100.3

32.7

3.25

126

356

(3028626) Oxygen [Partial pressure] in Capillary blood

215

812

2.74

39.65

4.9

2.7

kpa

7.7

7.9

1.36

202

741

(3022806) Fractional oxyhemoglobin in Capillary blood

142

423

3.44

39.49

2.2

1.7

88.3

89.3

0.93

142

417

(3032035) Polymorphonuclear cells/100 leukocytes in Blood

162

525

3.17

39.32

4.3

3.2

60.7

58.4

1.23

162

525

(3026008) Bacteria identified in Urine by Culture

1415

10277

1.58

38.79

3.6

3.4

—

(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum

281

1222

2.40

38.65

3.3

3.2

ratio

2.2

3.0

0.32

(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection

433

2243

2.04

38.61

2.1

1.7

—

(3044007) Cell count panel - Peritoneal fluid

6.95

38.55

1.7

2.2

—

(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma

285

1249

2.38

38.53

3.3

mg/l

72.1

54.7

0.38

232

1038

(3034860) Kappa light chains.free [Mass/volume] in Serum

285

1250

2.38

38.46

3.3

mg/l

173.3

104.9

0.26

234

1033

(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection

162

5.08

38.31

1.8

1.4

—

(3037692) Legionella sp identified in Specimen by Organism specific culture

6.99

38.12

1.6

1.3

—

(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection

163

5.05

38.04

1.8

1.4

—

(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection

108

275

4.01

37.77

1.8

1.4

—

(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection

108

275

4.01

37.77

1.8

1.4

—

(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection

108

275

4.01

37.77

1.8

1.4

—

(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture

609

3562

1.83

37.73

5.5

3.5

—

(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma

154

505

3.13

36.65

1.6

1.4

—

(44790049)

119

332

3.66

36.55

1.6

1.4

—

(44790048)

119

332

3.66

36.55

1.6

1.4

—

(44790047)

119

332

3.66

36.55

1.6

1.4

—

(44806118)

119

332

3.66

36.55

1.6

1.4

—

(3015171) Extractable nuclear Ab [Units/volume] in Serum

223

896

2.57

36.33

1.3

1.2

u/ml

1.0

0.4

0.82

(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection

101

252

4.08

36.31

2.0

1.4

—

(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma

594

3486

1.82

36.30

2.9

2.4

ug/l

6.2

7.2

1.01

509

2983

(40760888) Immunoglobulin light chains.free panel - Serum

228

934

2.53

35.67

2.9

3.4

—

(3015235) Bicarbonate [Moles/volume] in Capillary blood

226

924

2.53

35.51

4.0

2.7

mmol/l

25.3

24.5

1.53

199

792

(3021589) Normoblasts [#/volume] in Blood

1713

13162

1.52

35.48

18.2

9.7

e9/l

0.0

0.45

1418

10657

(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method

207

815

2.62

35.14

3.0

2.2

83.5

89.0

2.59

197

777

(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection

321

1538

2.18

35.04

2.5

1.9

—

(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay

199

779

2.63

34.18

2.5

1.5

—

(3001122) Ferritin [Mass/volume] in Serum or Plasma

1625

12419

1.51

34.12

4.2

2.8

ug/l

226.8

156.9

10.60

1507

11224

(3021901) Oxygen saturation in Capillary blood

181

676

2.76

34.09

3.8

2.4

—

(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection

119

5.53

33.91

1.8

1.4

—

(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection

121

5.44

33.31

1.9

1.4

—

(3018405) Lactate [Moles/volume] in Arterial blood

279

1294

2.24

32.97

6.4

3.2

mmol/l

1.3

1.4

1.02

270

1271

(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection

119

5.45

32.84

1.9

1.4

—

(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection

7.07

32.62

1.1

1.3

—

(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma

500

2886

1.83

32.01

3.0

2.4

u/l

38.1

38.8

0.05

433

2456

(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma

135

447

3.09

31.62

1.6

1.4

u/ml

114.7

120.2

0.19

(3003181) Sodium [Moles/volume] in Urine

165

611

2.77

31.59

1.5

1.4

mmol/l

55.3

62.7

1.59

126

490

(3037467) Urinalysis macro (dipstick) panel - Urine

2560

21644

1.49

31.57

6.0

4.5

—

(3002331) Protein [Mass/volume] in Peritoneal fluid

7.09

31.35

1.5

1.3

g/l

30.9

24.7

1.44

(3047181) Lactate [Moles/volume] in Blood

241

1079

2.31

30.95

6.1

mmol/l

1.3

1.4

0.52

222

956

(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection

291

1423

2.13

30.07

2.1

1.8

—

(3005895) Myoglobin [Mass/volume] in Serum or Plasma

264

1244

2.20

29.97

2.6

2.2

ug/l

462.5

718.2

0.67

248

1182

(4281824)

240

3.81

29.56

1.3

1.2

—

(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay

186

758

2.52

29.41

2.9

2.4

224.6

199.4

3.11

180

717

(3007164) IgA [Mass/volume] in Serum or Plasma

728

4788

1.63

28.90

1.7

1.5

g/l

3.0

2.7

2.77

490

2764

(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood

471

2757

1.80

28.64

6.4

3.5

mmol/l

1.2

3.39

438

2389

(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection

159

4.46

28.48

1.8

1.4

—

(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection

159

4.46

28.48

1.8

1.4

—

(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate

159

4.46

28.48

3.2

3.7

—

(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection

159

4.46

28.48

1.8

1.4

—

(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum

206

3.99

28.43

2.4

2.3

—

(3027456) Digoxin [Moles/volume] in Serum or Plasma

204

882

2.38

28.37

3.3

3.0

nmol/l

0.9

0.8

0.61

156

652

(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells

213

940

2.34

28.27

1.6

1.5

—

(3008757) Leukocyte morphology finding [Identifier] in Blood

119

391

3.10

28.27

5.9

3.8

—

(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma

1371

10418

1.48

28.13

2.6

2.1

u/l

198.8

222.8

0.57

1297

9713

(3052851) Hemolysis interference index of Serum or Plasma

223

1007

2.28

28.05

4.4

3.5

—

(3026493) Urate [Moles/volume] in Serum or Plasma

1184

8750

1.50

27.86

4.2

2.9

umol/l

4454.6

6189.3

0.64

1004

7411

(3026250) Tacrolimus [Mass/volume] in Blood

5.73

27.69

36.1

32.1

ug/l

6.9

7.0

0.19

(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection

159

4.40

27.58

1.8

1.4

—

(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum

199

3.98

27.27

1.2

—

(3007930) Methemoglobin/Hemoglobin.total in Blood

295

1509

2.03

26.98

6.5

5.1

0.9

0.34

280

1417

(3020891) Body temperature

280

1409

2.06

26.78

8.6

4.1

—

(3004119) Hemoglobin [Mass/volume] in Venous blood

395

2239

1.85

26.61

6.0

3.2

g/l

118.2

127.2

11.95

384

2175

(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood

297

1536

2.01

26.34

6.4

5.0

1.8

1.6

2.69

281

1444

(3013707) Erythrocyte sedimentation rate by Westergren method

2609

22520

1.44

26.08

6.0

4.0

mm/h

21.6

13.7

61.04

2421

20521

(3019309) Folate [Moles/volume] in Red Blood Cells

1033

7509

1.50

26.02

2.1

1.8

nmol/l

1198.3

1159.2

0.61

808

5555

(3024891) Influenza virus A+B Ag [Presence] in Specimen

168

694

2.48

25.82

1.2

1.1

—

(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis

229

1082

2.18

25.80

2.7

2.2

g/l

0.0

0.06

204

972

(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma

267

1343

2.06

25.56

2.7

3.3

u/ml

703.9

3087.4

0.63

222

1155

(3007566) Smooth muscle Ab [Titer] in Serum

168

701

2.46

25.27

1.2

titre

173.3

87.8

0.38

(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis

273

1395

2.03

25.02

2.8

2.3

g/l

10.4

10.3

0.13

232

1155

(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

286

1486

1.99

25.02

2.8

2.2

g/l

3.9

3.8

0.24

213

1034

(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

269

1369

2.03

24.93

2.8

2.3

g/l

3.4

3.1

5.63

215

1058

(3014444) EGFR gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal

11.37

24.90

1.1

1.0

—

(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

286

1489

1.99

24.87

2.8

2.2

—

(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

286

1490

1.99

24.82

2.8

2.2

g/l

7.6

7.3

1.55

220

1075

(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis

216

1013

2.20

24.79

2.8

2.3

g/l

0.0

0.50

193

908

(3042733) HLA Ab [Presence] in Serum

6.36

24.79

3.8

5.0

—

(3035637) Corticotropin [Mass/volume] in Plasma

105

348

3.07

24.61

1.6

—

(3023150) Myeloperoxidase Ab [Units/volume] in Serum

128

475

2.75

24.45

1.3

1.2

—

(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis

212

993

2.20

24.41

2.8

2.3

g/l

0.0

0.00

193

903

(40762485) Glomerular basement membrane Ab [Units/volume] in Serum by Immunoassay

237

3.51

23.98

1.2

1.1

u/ml

—

(3011412) CD3 cells [#/volume] in Blood

228

3.56

23.89

2.3

2.2

e9/l

0.9

1.1

1.68

137

(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum

118

425

2.83

23.85

1.3

1.2

u/ml

342.7

279.0

1.33

262

(3026692) Albumin [Mass/volume] in Peritoneal fluid

5.54

23.64

1.4

1.5

g/l

16.0

13.2

1.15

(3036489) Thrombin time

222

1074

2.13

23.55

2.7

2.0

22.6

21.7

1.61

204

977

(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis

246

1242

2.04

23.30

2.7

2.4

g/l

0.7

1.2

1.71

212

1040

(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis

231

1141

2.09

23.21

2.8

2.2

g/l

34.7

37.4

8.58

200

956

(3024928) Oxygen saturation in Venous blood

169

736

2.35

23.14

4.3

2.9

—

(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay

123

461

2.72

23.07

1.3

1.2

—

(3037121) Protein [Mass/volume] in Urine

238

1194

2.05

22.93

3.4

3.3

g/l

0.6

0.3

1.71

119

493

(3024889) Methemoglobin/Hemoglobin.total in Venous blood

307

1683

1.89

22.90

4.7

2.6

0.7

0.14

298

1603

(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood

170

3.93

22.82

1.6

2.3

—

(3043409) Potassium [Moles/volume] in Arterial blood

224

1103

2.09

22.69

7.5

3.4

mmol/l

4.0

3.9

1.29

206

1026

(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma

2129

17966

1.39

22.65

4.6

3.1

u/l

76.3

55.4

9.36

1955

16346

(3027273) Bicarbonate [Moles/volume] in Venous blood

329

1859

1.84

22.30

6.2

3.3

mmol/l

25.5

24.9

2.40

318

1797

(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma

891

6462

1.48

22.17

4.3

3.1

mmol/l

2.5

11.69

778

5616

(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count

784

5550

1.51

21.93

4.0

3.2

e6/l

1.7

0.15

470

3164

(3018572) Chloride [Moles/volume] in Blood

171

774

2.26

21.41

6.8

7.1

mmol/l

104.4

105.4

1.54

158

689

(3039000) Anion gap in Blood

171

774

2.26

21.41

6.8

7.0

mmol/l

10.7

11.5

3.01

158

689

(3006184) Hemoglobin [Mass/volume] in Capillary blood

170

777

2.24

20.80

3.2

2.1

g/l

120.8

128.4

3.10

124

572

(4010399)

349

2052

1.77

20.69

1.6

1.4

—

(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma

617

4195

1.55

20.69

1.3

1.2

iu/ml

58.2

38.3

1.52

203

1292

(40761536) Microorganisms panel - Urine sediment

407

2506

1.69

20.44

5.6

4.0

—

(1175426) CD3 cells/100 lymphocytes in Blood

175

3.70

20.36

1.7

2.2

69.0

71.6

0.55

162

(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum

146

631

2.36

20.36

1.3

—

(3042602) Urea [Moles/volume] in Serum or Plasma --post dialysis

6.93

20.35

10.2

13.7

mmol/l

5.7

5.5

0.08

(3048929) Epstein Barr virus Ab [Presence] in Serum

141

602

2.39

20.21

1.3

1.2

—

(21494815) CD4 cells/100 lymphocytes in Specimen

191

3.55

20.05

1.9

2.2

33.7

44.2

—

(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma

305

2.96

19.74

1.2

u/l

53.1

60.1

0.54

204

(3027831) CD3-CD16+CD56+ (Natural killer) cells/100 cells in Blood

169

3.65

19.06

1.7

2.2

18.6

14.9

0.59

(3017354) Segmented neutrophils/100 leukocytes in Blood

367

2.74

19.02

4.3

3.4

62.6

58.3

0.94

213

(3010375) cycloSPORINE [Mass/volume] in Blood

112

4.32

18.96

31.8

25.2

ug/l

120.0

116.2

0.14

(3004437) Lymphocytes/100 leukocytes in Peritoneal fluid

10.05

18.48

2.3

1.7

57.1

59.7

0.09

(42529201) Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay

156

731

2.18

17.99

2.9

3.1

u/ml

522.1

728.2

0.21

141

672

(21494814) CD8 cells/100 lymphocytes in Specimen

4.60

17.95

1.8

2.0

—

(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count

181

3.46

17.93

4.9

3.0

—

(46234826) Other cells/100 leukocytes in Peritoneal fluid by Manual count

10.60

17.32

2.0

1.6

8.2

23.0

0.90

(21494890) Protein electrophoresis panel - 24 hour Urine

101

397

2.58

17.31

2.2

2.0

—

(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen

4.73

17.26

1.6

2.1

—

(40768804) Tissue Pathology biopsy report

1478

12114

1.35

17.26

2.6

2.2

—

(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability

115

484

2.42

17.07

1.2

1.3

—

(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal

198

3.27

16.92

1.2

—

(3030366) Cystatin C [Mass/volume] in Serum or Plasma

162

795

2.08

16.60

3.7

3.3

mg/l

2.2

1.7

6.30

149

698

(40768446) Kidney Pathology biopsy report

4.30

16.16

1.5

1.7

—

(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count

789

5895

1.42

16.13

3.8

3.0

e6/l

1.2

0.02

480

3468

(3043453) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum

199

3.20

16.12

1.2

1.1

titre

190.0

114.7

—

(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture

335

2.63

15.58

4.8

2.9

—

(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

119

534

2.27

15.29

1.4

1.1

u/ml

1.3

4.4

0.87

(40758310) Human epididymis protein 4 [Moles/volume] in Serum or Plasma

399

2.47

15.17

1.4

1.5

pmol/l

414.1

214.2

1.44

391

(3016921) Smith extractable nuclear Ab [Units/volume] in Serum

135

640

2.15

15.16

1.5

1.2

u/ml

3.6

2.8

0.28

(3014271) Vancomycin [Susceptibility]

229

2.96

15.02

2.6

3.1

—

(4015189)

4.69

14.92

1.6

1.9

—

(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

1482

12343

1.32

14.87

2.6

2.2

nmol/l

78.1

78.4

0.11

1299

10760

(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma

185

3.17

14.63

1.8

1.6

u/l

8.4

7.1

0.18

(3028167) CD3+CD4+ (T4 helper) cells [#/volume] in Blood

170

3.27

14.61

2.6

1.9

e6/l

378.8

680.1

2.49

(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum

135

651

2.11

14.53

1.5

1.2

u/ml

3.3

5.8

0.76

(3027450) Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum

140

685

2.08

14.50

1.5

1.2

u/ml

34.6

45.8

0.28

(3051651) Icteric interference index of Serum or Plasma

197

3.08

14.43

5.9

3.5

—

(3011363) Streptococcus pneumoniae Ag [Presence] in Urine

236

2.87

14.25

1.1

—

(3025941) Bacteria identified in Stool by Culture

247

1465

1.73

14.17

1.3

—

(3019977) pH of Arterial blood

191

3.07

13.89

1.8

2.4

7.4

0.02

(3008536) Aspergillus sp Ab [Presence] in Serum

5.12

13.62

1.7

1.4

—

(3004905) Lipase [Enzymatic activity/volume] in Serum or Plasma

4.94

13.56

6.2

3.1

u/l

38.9

44.6

0.40

(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection

244

2.78

13.42

1.4

—

(3045684) Alkaline phosphatase.other fractions [Enzymatic activity/volume] in Serum or Plasma

176

3.10

13.18

1.3

1.2

u/l

48.0

22.9

1.61

145

(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection

241

2.77

13.16

1.5

1.4

—

(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot

139

3.34

12.70

1.1

—

(3000492) Spirometry study

350

2329

1.55

12.68

1.8

1.5

—

(3017569) Oxygen content in Arterial blood

165

3.12

12.61

1.9

2.1

—

(3026285) Alpha 1 antitrypsin [Mass/volume] in Serum or Plasma

373

2.33

12.04

1.1

g/l

1.7

1.5

1.91

332

(3020460) C reactive protein [Mass/volume] in Serum or Plasma

3202

29910

1.33

12.04

38.9

16.3

mg/l

33.2

27.5

15.35

3018

24377

(3043109) Cytology report of Tissue fine needle aspirate Cyto stain

138

722

1.94

11.92

1.3

1.2

—

(3009214) Lutropin [Units/volume] in Serum or Plasma

103

484

2.16

11.91

1.4

u/l

13.0

10.0

1.02

384

(3001964) Herpes simplex virus Ag [Presence] in Specimen

4.25

11.72

2.0

1.3

—

(3000570) Elastase.pancreatic [Mass/mass] in Stool

163

906

1.83

11.70

1.3

1.4

ug/g

249.8

274.9

0.85

102

540

(42529215) Follitropin [Units/volume] in Serum or Plasma by Immunoassay

189

2.88

11.68

1.5

1.4

u/l

22.4

28.0

0.76

152

(3015736) pH of Urine

1391

11780

1.27

11.48

4.3

3.6

—

5.9

—

(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma

2753

29625

0.78

11.46

5.1

5.3

mmol/l

2.4

2.6

15.30

2413

26729

(3044927) Protein electrophoresis panel - Urine

420

2.22

11.44

1.2

—

(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma

2638

28506

0.79

11.19

4.7

mmol/l

1.3

1.4

11.25

2322

25667

(3039162) Centromere protein B Ab [Units/volume] in Serum

287

2.46

11.12

1.5

1.2

u/ml

85.5

37.3

—

(3049714) Procollagen type I.N-terminal propeptide [Mass/volume] in Serum

106

3.51

11.12

2.6

1.8

ug/l

62.5

67.7

0.11

101

(3035350) Ketones [Presence] in Urine by Test strip

1720

14991

1.25

10.99

4.9

3.8

estimate

0.0

0.00

434

2689

(3019900) Cholesterol [Moles/volume] in Serum or Plasma

2671

28801

0.79

10.98

4.7

mmol/l

4.2

4.4

19.33

2367

26142

(3005322) IgE [Units/volume] in Serum or Plasma

220

1360

1.65

10.86

1.3

u/ml

204.1

234.9

0.24

211

1248

(3014037) CD3+CD4+ (T4 helper) cells/100 cells in Blood

159

2.98

10.82

2.1

2.6

39.9

34.1

1.03

(3019225) pH of Specimen

482

3534

1.41

10.67

7.5

4.4

—

(3024471) HLA-A [Type]

4.05

10.66

1.0

—

(3029937) Albumin [Presence] in Urine by Test strip

1013

8307

1.29

10.65

5.4

4.2

estimate

0.0

0.26

397

2539

(3001405) CD3+CD8+ (T8 suppressor) cells [#/volume] in Blood

156

2.97

10.55

2.7

2.2

e6/l

367.6

566.8

1.69

134

(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum

535

4002

1.39

10.53

1.3

1.2

u/ml

18.7

13.5

0.68

174

1439

(3013327) Hepatitis A virus IgM Ab [Presence] in Serum

403

2.18

10.47

1.0

1.1

—

(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot

173

2.85

10.47

1.1

1.2

—

(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot

173

2.85

10.47

1.1

1.2

—

(40759836) Histone Ab [Presence] in Serum by Immunoblot

173

2.85

10.47

1.1

1.2

—

(3024932) HLA-DR beta [Type]

4.08

10.40

1.1

—

(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot

176

2.81

10.15

1.1

—

(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot

176

2.81

10.15

1.1

—

(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot

176

2.81

10.15

1.1

—

(3025271) CD3-CD16+CD56+ (Natural killer) cells [#/volume] in Blood

149

2.97

10.13

2.8

2.2

e9/l

0.2

0.53

133

(3045142) Bone marrow Pathology biopsy report

390

2.18

10.07

1.4

1.2

—

(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection

128

696

1.87

9.90

1.4

—

(3047189) Immunofixation for 24 hour Urine

190

2.71

9.88

1.6

1.7

—

(3016650) Hepatitis A virus Ab [Presence] in Serum

387

2.17

9.85

1.0

1.1

—

(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells

191

2.69

9.78

1.7

1.6

—

(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells

191

2.69

9.78

1.7

1.6

—

(3021601) Nitrite [Presence] in Urine by Test strip

1707

15005

1.24

9.69

6.5

5.2

estimate

0.0

0.50

439

2706

(3008295) Osmolality of Serum or Plasma

332

2.25

9.65

1.4

mosm/kgh2o

268.5

277.7

2.47

244

(3009261) Glucose [Presence] in Urine by Test strip

1727

15207

1.24

9.63

5.0

3.9

estimate

0.0

1.08

428

2621

(40768797) Stomach Pathology biopsy report

555

4241

1.36

9.52

1.3

—

(3000093) Morphology [Interpretation] in Blood Narrative

361

2.18

9.45

1.1

—

(3013512) EKG study

1184

10019

1.26

9.42

6.1

4.3

—

(3004451) EKG impression Narrative

167

2.77

9.37

1.2

—

(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum

453

2.03

9.14

1.5

1.1

u/ml

37.4

50.2

0.37

(3006695) Toxoplasma gondii DNA [Presence] in Specimen by NAA with probe detection

5.95

9.12

2.8

1.6

—

(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma

221

1430

1.58

9.09

3.4

3.3

pmol/l

4.0

4.4

5.67

188

1225

(3042111) Morphology [Interpretation] in Bone marrow Narrative

119

652

1.85

9.02

1.7

1.5

—

(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum

422

2.06

8.98

1.2

—

(3012568) Campylobacter sp identified in Specimen by Organism specific culture

425

2.05

8.82

1.6

1.4

—

(3005988) Vibrio sp identified in Specimen by Organism specific culture

419

2.05

8.78

1.6

1.4

—

(3028433) Virus identified in Specimen by Culture

3.32

8.60

1.1

—

(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection

181

2.62

8.58

1.6

1.4

—

(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection

181

2.62

8.58

1.6

1.4

—

(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay

205

2.51

8.54

1.0

1.1

—

(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection

417

2.04

8.52

1.6

1.4

—

(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection

417

2.04

8.52

1.6

1.4

—

(3025468) Yersinia sp identified in Specimen by Organism specific culture

418

2.03

8.47

1.6

1.4

—

(3028371) Actinomyces sp identified in Specimen by Organism specific culture

4.88

8.35

1.2

1.1

—

(3024522) Salmonella sp identified in Specimen by Organism specific culture

421

2.02

8.31

1.6

1.4

—

(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence

197

2.51

8.21

1.1

—

(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay

3.91

8.14

1.1

1.0

—

(3011985) Renin [Units/volume] in Plasma

378

2.06

8.07

1.7

1.4

mu/l

80.6

64.6

0.28

336

(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum

4.02

8.06

1.1

1.0

—

(3041096) Erythrocytes [Presence] in Urine by Automated

930

7785

1.25

7.91

5.1

3.6

—

(3025315) Body weight

5.85

7.85

5.0

4.3

—

(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

353

2.06

7.60

1.3

1.2

u/ml

4.9

3.3

0.31

118

(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture

140

2.73

7.59

1.5

1.3

—

(3051611) Lipemic interference index of Serum or Plasma

354

2.05

7.54

5.6

3.4

—

(3032352) Blasts [#/volume] in Cerebral spinal fluid

5.92

7.37

1.9

2.5

—

(3006571) Polymorphonuclear cells/100 leukocytes in Synovial fluid

385

1.99

7.35

1.5

64.3

63.7

0.05

234

(3006922) Hepatitis E virus Ab [Presence] in Serum

160

2.58

7.34

1.0

1.1

—

(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma

108

614

1.78

7.33

1.3

u/l

42.7

45.6

0.11

532

(3025839) Triglyceride [Moles/volume] in Serum or Plasma

637

7796

0.78

7.24

1.8

1.6

mmol/l

1.4

1.3

1.21

522

6492

(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma

892

7502

1.24

7.19

1.8

1.7

pmol/l

17015786.9

25312921.0

0.27

717

6080

(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma

122

2.80

7.15

2.8

2.5

—

(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay

157

2.56

7.09

1.3

1.2

—

(40768441) Liver Pathology biopsy report

188

2.41

7.00

1.7

1.4

—

(3017732) Neutrophils [#/volume] in Blood

274

1960

1.43

6.97

3.9

3.2

e9/l

4.5

4.2

0.72

199

1402

(3004410) Hemoglobin A1c/Hemoglobin.total in Blood

2639

28041

0.83

6.89

7.1

6.5

mmol/mol

42.0

40.9

5.59

2339

25491

(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay

346

2.01

6.89

1.3

1.2

u/ml

5.0

5.3

0.04

160

(3001788) Aldosterone [Moles/volume] in Serum or Plasma

348

2.00

6.78

1.1

1.4

pmol/l

228.0

265.2

0.55

263

(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting

2598

27610

0.84

6.63

4.3

4.2

mmol/l

1.3

0.43

2277

24608

(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC

175

2.41

6.59

2.9

1.9

—

(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay

151

2.53

6.59

1.1

1.0

—

(3002222) Hepatitis E virus IgM Ab [Presence] in Serum

151

2.53

6.59

1.1

1.0

—

(1761868) Lipid panel - Serum or Plasma

717

8555

0.80

6.44

3.3

3.2

—

(1001833) Epstein Barr virus DNA [Units/volume] (viral load) in Blood by NAA with probe detection

3.93

6.43

1.2

1.8

—

(3009347) Lactate dehydrogenase isoenzymes [Interpretation] in Serum or Plasma

6.12

6.43

1.2

1.1

—

(40757373) Influenza virus identified in Isolate

3.21

6.41

1.9

1.3

—

(42529406) Shigella sp [Presence] in Stool by Culture

134

844

1.61

6.28

1.3

1.2

—

(3017704) Immunofixation for Urine

224

2.20

6.24

1.6

1.4

—

(3006418) Campylobacter sp identified in Tissue by Organism specific culture

132

830

1.61

6.23

1.3

1.2

—

(3048879) Bone marrow aspiration report

109

2.77

6.20

1.8

1.3

—

(3048518) aPTT.lupus sensitive actual/normal (normalized LA screen)

109

2.77

6.20

1.1

1.2

ratio

1.0

1.1

—

(3014765) Yersinia sp identified in Stool by Organism specific culture

133

839

1.60

6.19

1.3

1.2

—

(3021788) Differential panel - Synovial fluid

572

1.73

6.14

1.5

—

(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection

1630

14706

1.18

6.08

2.9

2.4

—

(3004616) Nuclear Ab [Presence] in Serum

344

1.93

5.96

1.4

1.2

—

(3021960) Folate [Moles/volume] in Serum or Plasma

995

8614

1.21

5.89

1.9

1.6

nmol/l

20.4

19.7

0.52

876

7255

(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma

512

1.75

5.88

4.7

2.9

—

(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma

1516

0.59

5.85

1.6

1.8

—

(3040151) Glucose [Moles/volume] in Capillary blood

441

1.81

5.78

8.1

10.7

mmol/l

6.7

7.7

2.28

354

(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma

246

2.09

5.71

2.1

1.8

u/l

6096.7

2252.5

0.41

(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood

3.11

5.61

4.0

1.9

—

(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma

343

2640

1.33

5.59

1.8

1.7

1.6

2.73

280

2238

(40761539) Cells [Type] in Urine sediment by Light microscopy

2.94

5.56

1.4

1.1

—

(21494755) Public health laboratory ask at order entry panel

1295

0.57

5.54

1.4

—

(3019832) Treponema pallidum Ab [Presence] in Serum

153

1025

1.51

5.51

1.6

1.5

—

(3046299) Protein.monoclonal [Mass/volume] in Serum or Plasma by Electrophoresis

4.49

5.50

2.8

3.9

—

(3011391) Calcitriol [Moles/volume] in Serum or Plasma

223

2.12

5.50

1.9

1.2

—

(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip

1292

11525

1.18

5.36

5.4

4.2

—

(3003694) ABO and Rh group [Type] in Blood

882

7614

1.20

5.32

1.4

1.3

—

(3044242) Glucose [Moles/volume] in Arterial blood

200

2.16

5.30

1.6

1.9

—

(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay

2.83

5.24

1.4

1.3

—

(3036185) Alkaline phosphatase.liver 2 [Enzymatic activity/volume] in Serum or Plasma

150

2.34

5.23

1.1

u/l

31.9

32.2

0.01

107

(3033705) Calcium.ionized [Moles/volume] in Venous blood

516

1.70

5.21

4.3

2.4

—

(3015479) Mycobacterium sp identified in Blood by Organism specific culture

3.34

5.16

2.2

1.3

—

(3050238) Crystals [Presence] in Synovial fluid by Light microscopy

136

903

1.52

5.13

1.4

—

(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence

496

1.71

5.11

1.2

1.1

—

(3002385) Erythrocyte distribution width [Ratio]

2525

23769

1.16

5.11

44.4

20.1

14.8

13.9

116.82

2476

23152

(3043722) Hyaline casts [#/area] in Urine sediment by Automated count

13.36

5.07

1.0

u/field

1.4

1.2

—

(21494434) Karyotype in Bone marrow

321

1.88

5.07

1.3

1.2

—

(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum

147

2.32

5.00

1.3

u/ml

0.3

2.0

1.26

(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay

3.04

4.94

1.0

—

(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma

974

0.54

4.92

1.3

1.5

—

(4268621)

234

2.02

4.89

2.2

2.3

—

(40761535) Cells panel - Urine sediment

368

2915

1.29

4.87

4.5

3.5

—

(3018251) Fasting glucose [Moles/volume] in Serum or Plasma

2779

29115

0.86

4.85

5.2

5.0

mmol/l

6.2

6.1

3.31

2425

25925

(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum

3.07

4.78

1.1

—

(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex

126

2.39

4.72

1.3

1.1

—

(3052592) Norovirus Ag [Presence] in Stool

2.79

4.71

1.2

1.3

—

(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method

315

1.85

4.70

1.2

1.1

—

(3018461) Alpha 1 globulin [Mass/time] in 24 hour Urine by Electrophoresis

4.15

4.62

3.3

4.3

ug/min

71.7

62.6

0.10

(3003329) Lymphocytes/100 leukocytes in Synovial fluid

317

1.84

4.62

1.7

1.4

24.2

25.8

0.16

201

(4306422)

310

1.85

4.61

1.2

—

(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum

413

1.73

4.60

1.2

1.3

miu/ml

243.1

216.3

0.12

141

(3016251) Hemoglobin.gastrointestinal [Presence] in Stool

248

1881

1.34

4.51

2.5

—

(3012320) Pathologist interpretation of Cerebral spinal fluid tests

3.06

4.51

1.1

1.2

—

(43054903) Holo-transcobalamin II [Moles/volume] in Serum

1586

14545

1.15

4.33

2.4

2.1

pmol/l

91.3

92.0

0.24

890

7656

(3044889) 12 lead EKG panel

2318

21836

1.14

4.21

5.6

4.2

—

(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma

2.56

4.21

2.9

2.5

—

(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma

1130

12532

0.86

4.16

4.4

4.7

21.9

22.3

0.32

604

6623

(3002621) Streptococcal DNAse B [Units/volume] in Serum

4.08

4.16

1.1

—

(3009550) Parvovirus B19 IgG Ab [Titer] in Serum

3.09

4.08

1.1

—

(3008116) Ketones [Moles/volume] in Urine by Test strip

2.76

4.01

1.3

—

(3003327) Ova and parasites identified in Stool by Light microscopy

109

731

1.50

4.01

1.5

1.6

—

(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)

320

2557

1.27

3.99

4.5

2.8

ml/min/173m2

52.6

61.7

4.52

170

1082

(3022493) Free Hemoglobin [Mass/volume] in Plasma

153

2.10

3.77

1.3

2.7

mg/l

57.7

71.3

0.84

105

(40768795) Lymph node Pathology biopsy report

273

1.80

3.74

1.4

1.1

—

(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture

181

2.00

3.72

2.3

2.5

—

(3050794) Legionella sp Ab [Presence] in Serum

4.01

3.69

1.3

1.1

—

(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method

740

0.55

3.67

1.6

1.7

mg/l

5.5

3.5

0.41

537

(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot

2.61

3.63

1.3

1.1

—

(42529582) MDA5 Ab [Presence] in Serum by Line blot

2.61

3.63

1.3

1.1

—

(3013637) Mi-2 Ab [Presence] in Serum

2.61

3.63

1.3

1.1

—

(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot

2.61

3.63

1.3

1.1

—

(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood

190

1.96

3.62

1.9

—

(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood

110

2.28

3.61

1.9

2.1

—

(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood

110

2.28

3.61

1.9

2.1

—

(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma

785

8858

0.86

3.57

3.1

3.3

ug/l

0.8

0.14

571

6336

(3002256) Pathology report gross observation

492

4172

1.20

3.55

1.4

—

(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection

234

1.85

3.55

1.3

1.2

—

(3012447) Hantavirus puumala IgG Ab [Titer] in Serum

315

1.72

3.54

1.1

—

(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma

2.81

3.52

1.0

1.1

—

(3043870) Heparin induced platelet Ab [Units/volume] in Serum

3.18

3.49

1.3

1.2

—

(3011648) Oxygen content in Venous blood

251

1.80

3.44

2.6

2.3

10.8

0.00

251

(3011397) Hemoglobin [Presence] in Urine by Test strip

821

7287

1.16

3.43

4.2

3.8

—

(3034891) Synovial lining cells/100 cells in Synovial fluid

154

2.02

3.34

1.5

1.4

2.8

3.9

—

(3036525) Urea [Moles/time] in 24 hour Urine

5.72

3.34

3.0

3.7

—

(3009340) Metanephrine [Moles/volume] in Serum or Plasma

321

1.69

3.33

1.2

1.3

nmol/l

—

(3022756) Ceruloplasmin [Mass/volume] in Serum or Plasma

212

1.85

3.26

1.0

mg/l

308.0

286.3

0.94

183

(3019539) Treponema pallidum Ab [Titer] in Serum by Hemagglutination

279

1.73

3.22

1.4

1.6

—

1221.8

—

(3004716) Salmonella sp identified in Stool by Organism specific culture

150

1115

1.36

3.21

1.3

—

(3010254) Herpes simplex virus identified in Specimen by Organism specific culture

2.58

3.21

1.3

1.1

—

(3020191) Ethanol [Moles/volume] in Serum or Plasma

206

1.85

3.20

1.5

1.3

promille

1.0

1.1

0.19

165

(3014148) Varicella zoster virus Ab [Titer] in Serum

207

1.84

3.16

1.1

—

(3045716) Anion gap in Serum or Plasma

179

1.91

3.14

3.6

2.2

mmol/l

8.3

9.5

0.72

137

(3024869) Neuronal Ab [Presence] in Serum

2.63

3.13

1.3

1.1

—

(3005791) Eosinophil cationic protein (ECP) [Mass/volume] in Serum

2.25

3.12

1.5

1.8

ug/l

24.5

100.6

0.47

(3000504) BK virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

3.08

2.8

5.4

—

(40768443) Skin Pathology biopsy report

182

1402

1.31

3.07

1.2

—

(3013803) Aspergillus fumigatus IgG Ab [Mass/volume] in Serum

3.24

3.05

1.0

1.2

—

(3020485) Acetaminophen [Moles/volume] in Serum or Plasma

2.23

3.05

1.8

1.7

umol/l

73.3

91.4

0.22

(40763091) Bacteria identified in Peritoneal dialysis fluid by Culture

5.01

3.05

4.8

3.1

—

(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay

403

1.57

2.96

1.9

1.5

—

(3030408) 3-Methoxytyramine [Moles/volume] in Serum or Plasma

372

1.59

2.94

1.2

1.3

nmol/l

0.3

—

(3005812) Immunoglobulin light chains [Presence] in 24 hour Urine

3.15

2.93

3.5

1.8

—

(3023091) Interleukin 6 [Mass/volume] in Serum or Plasma

2.83

2.91

1.2

ng/l

252.2

110.9

—

(44816808) CXCL13 Ag [Mass/volume] in Cerebral spinal fluid

115

2.09

2.88

1.0

1.1

ng/l

108.8

451.0

—

(1176173) BK virus + JC virus DNA [Presence] in Specimen by NAA with probe detection

5.39

2.87

5.3

6.5

—

(40757494) Bilirubin.total [Moles/volume] in Blood

193

1.82

2.83

2.5

2.1

umol/l

14.0

33.4

—

(3017044) Thyrotropin receptor Ab [Units/volume] in Serum

570

1.47

2.82

1.8

1.7

iu/l

4.5

4.1

0.12

177

(3002619) Bacteria identified in Specimen by Culture

2.55

2.78

1.3

1.2

—

(3009542) Hematocrit [Volume Fraction] of Blood

2693

25913

1.12

2.77

37.5

18.1

36.7

38.8

17.92

1621

16354

(3034426) Prothrombin time (PT)

2.31

2.74

1.3

—

(43054914) Glucose tolerance 2 hours panel - Serum or Plasma

223

2752

0.80

2.71

1.6

—

(3032057) Clostridioides difficile [Presence] in Stool

2.24

2.70

2.4

1.8

—

(3000475) Leukocytes [#/volume] in Synovial fluid

107

777

1.39

2.70

1.6

e6/l

13235.0

15251.0

0.27

547

(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay

249

1.69

2.68

1.1

—

(3048689) Calprotectin [Mass/mass] in Stool

343

2893

1.20

2.67

2.0

2.2

ug/g

217.4

162.3

1.22

275

2250

(3044941) Cell count panel - Synovial fluid

506

1.47

2.60

1.5

1.4

—

(3035320) C reactive protein [Mass/volume] in Body fluid

216

1.72

2.51

3.0

2.3

—

(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep

201

2483

0.80

2.49

1.3

1.4

—

(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method

470

1.48

2.48

2.4

2.1

mg/l

32.7

23.5

0.64

(3019768) Coxiella burnetii Ab [Presence] in Serum

4.38

2.47

1.0

1.4

—

(40771901) t(9;22)(q34.1;q11)(ABL1,BCR) b2a2+b3a2 fusion transcript/control transcript (International Scale) [# Ratio] in Blood or Tissue by Molecular genetics method

4.38

2.47

12.6

9.1

—

(1002224) Polysomnography panel

816

0.66

2.47

1.0

1.1

—

(3021387) Prolactin [Units/volume] in Serum or Plasma

479

1.47

2.46

2.0

1.7

mu/l

338.9

301.6

0.54

439

(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum

604

5370

1.15

2.46

1.3

1.2

u/ml

0.9

1.7

4.44

139

1378

(3039443) Prostate specific Ag panel - Serum or Plasma

570

0.59

2.44

1.4

1.7

—

(3016018) Differential panel - Cerebral spinal fluid

265

1.63

2.41

1.4

1.5

—

(3037826) lamoTRIgine [Moles/volume] in Serum or Plasma

3.34

2.39

2.3

2.1

umol/l

21.3

17.5

—

(3020393) Adenovirus Ag [Presence] in Stool

3.34

2.39

1.0

—

(3013293) Extractable nuclear Ab [Presence] in Serum

3.34

2.39

1.8

1.6

—

(3046861) Legionella sp Ag [Presence] in Urine

4.12

2.36

1.0

—

(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay

569

1.41

2.32

1.3

—

(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid

230

1.66

2.29

1.0

1.1

—

(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma

340

1.54

2.29

1.2

1.3

—

(3017895) Helicobacter pylori Ab [Units/volume] in Serum

124

950

1.31

2.26

1.6

—

(21494567) Legionella sp IgM Ab [Presence] in Serum

3.89

2.25

1.4

1.1

—

(3032743) Legionella sp IgG Ab [Presence] in Serum

3.89

2.25

1.4

1.1

—

(3020682) Albumin/Creatinine [Ratio] in Urine

1187

11040

1.11

2.24

4.5

4.0

mg/mmol

25.0

8.9

8.76

793

7108

(1761482) Bacteria [#/volume] in Urine by Culture

135

1049

1.30

2.23

5.2

4.4

—

(3005880) Parainfluenza virus 3 Ag [Presence] in Specimen

3.11

2.22

2.2

1.0

—

(3010464) Parainfluenza virus 1 Ag [Presence] in Specimen

3.11

2.22

2.2

1.0

—

(3021578) Parainfluenza virus 2 Ag [Presence] in Specimen

3.11

2.22

2.2

1.0

—

(3035401) Herpes virus 6 DNA [Presence] in Specimen by NAA with probe detection

5.56

2.21

1.4

1.0

—

(3029075) Extractable nuclear Ab panel - Serum

2.20

1.1

1.0

—

(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum

2.20

1.4

1.3

ug/l

10.4

9.3

0.44

(40758292) HTLV I+II Ab panel - Serum

2.78

2.20

1.3

—

(3000060) B lymphocytes [#/volume] in Blood

2.41

2.19

1.5

2.4

e6/l

186.7

319.0

—

(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection

2.41

2.19

1.7

1.2

—

(3035509) Tobramycin [Mass/volume] in Serum or Plasma

3.34

2.18

2.3

mg/l

1.6

1.2

—

(3001334) Neutrophil cytoplasmic Ab [Units/volume] in Serum

3.69

2.15

1.1

—

(3051593) INR in Capillary blood by Coagulation assay

204

1.67

2.14

12.2

14.9

—

(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay

2.37

2.12

1.2

1.1

—

(4198724)

2.45

2.10

2.2

1.5

—

(3049717) Cytology report of Urine Cyto stain

209

1724

1.22

2.10

3.0

2.8

—

(3009466) Valproate [Moles/volume] in Serum or Plasma

422

1.45

2.08

5.8

4.4

umol/l

358.9

339.5

0.53

352

(3006804) Neuronal Ab [Presence] in Cerebral spinal fluid

3.50

2.05

1.0

1.1

—

(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells

103

1.95

2.05

1.2

—

(3026389) Candida sp identified in Specimen by Organism specific culture

350

1.49

2.04

1.4

—

(40765096) Chromosome analysis panel by Banding

111

1.90

2.00

1.2

1.1

—

(3021513) Carbon dioxide [Partial pressure] in Mixed venous blood

2.00

6.1

8.3

—

(3018851) Theophylline [Moles/volume] in Serum or Plasma

2.82

2.00

1.1

1.5

umol/l

36.3

47.8

—

(3003245) Complement C1 esterase inhibitor [Mass/volume] in Serum or Plasma

2.08

1.96

1.2

g/l

0.3

1.42

(44816559) Phosphatidylethanol [Mass/volume] in Blood

437

1.43

1.94

1.6

1.3

—

(3027974) Hepatitis B virus e Ag [Presence] in Serum

4.55

1.94

3.2

1.0

—

(3013945) Hepatitis B virus e Ab [Presence] in Serum

4.55

1.94

3.2

1.0

—

(3022411) Androstenedione [Moles/volume] in Serum or Plasma

3.75

1.93

1.0

2.1

nmol/l

3.6

4.1

—

(3014300) Beta 2 glycoprotein 1 IgM Ab [Units/volume] in Serum

2.57

1.92

1.0

1.2

—

(3019550) Sodium [Moles/volume] in Serum or Plasma

3218

31472

1.11

1.91

43.1

19.7

mmol/l

138.5

139.6

77.46

3144

30580

(42869593) Oxyhemoglobin/Hemoglobin.total [Pure mass fraction] in Capillary blood

2.06

1.90

2.8

2.4

—

(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay

575

1.36

1.89

1.1

—

(3001019) Free T4 and TSH panel - Serum or Plasma

721

0.69

1.88

1.6

1.7

—

(3020491) Glucose [Moles/volume] in Blood

228

1.58

1.87

1.8

mmol/l

7.7

7.0

0.79

140

(3022192) Triglyceride [Mass/volume] in Serum or Plasma

114

1.85

1.87

3.3

2.5

—

(4094501)

813

0.71

1.86

1.1

—

(40761511) CBC panel - Blood by Automated count

3119

30469

1.10

1.86

34.9

15.9

—

(3016750) Collection duration of Urine

206

1.61

1.82

1.6

1.9

min

509.9

490.5

0.22

142

(3002067) Lambda light chains [Mass/time] in 24 hour Urine

2.13

1.81

4.6

3.1

—

(3009991) Angiotensin converting enzyme [Enzymatic activity/volume] in Cerebral spinal fluid

123

1.79

1.0

1.1

u/l

0.9

1.2

4.18

(3044290) Cell count panel - Cerebral spinal fluid

539

1.36

1.77

1.4

—

(40768800) Prostate Pathology biopsy report

1041

0.75

1.73

1.1

1.2

—

(3000012) Reticulocyte production index

202

1.59

1.71

1.6

1.5

—

(3014326) Insulin-like growth factor-I [Moles/volume] in Serum or Plasma

187

1.61

1.68

1.7

1.9

nmol/l

15.9

16.0

0.02

173

(3036603) Volume of Urine

203

1.58

1.68

2.5

1.7

1900.8

1764.2

0.20

(3023103) Potassium [Moles/volume] in Serum or Plasma

3218

31529

1.10

1.67

43.4

19.9

mmol/l

4.1

4.0

14.36

3137

30594

(3024474) Albumin [Mass/volume] in Cerebral spinal fluid

164

1.65

1.67

1.0

1.1

mg/l

230.9

298.6

1.32

137

(3007368) IgG [Mass/volume] in Cerebral spinal fluid

172

1.63

1.67

1.1

mg/l

35.4

45.8

1.00

140

(3010144) Erythrocytes [#/volume] in Synovial fluid

317

1.46

1.66

1.4

1.3

e6/l

71779.5

111092.7

0.34

227

(3013139) Helicobacter pylori Ag [Presence] in Stool

153

1850

0.82

1.64

1.2

—

(3038071) Oxygen [Partial pressure] in Mixed venous blood

1.98

1.64

5.3

8.6

—

(3022475) Manganese [Moles/volume] in Blood

3.57

1.61

1.2

1.4

—

(3028707) Methadone [Presence] in Urine by Screen method

166

1.63

1.61

2.5

—

(3041678) Intrinsic coagulation system thromboelastography panel - Blood

3.00

1.58

1.2

—

(3003338) MCHC [Mass/volume]

2326

23994

0.93

1.56

48.4

22.0

g/l

328.3

332.0

59.73

2286

23706

(3034274) Bile acid [Moles/volume] in Serum --fasting

152

1.65

1.56

1.1

2.1

umol/l

22.8

14.0

0.27

(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection

137

1.68

1.55

1.2

—

(43055514) Macroprolactin [Presence] in Serum or Plasma

2.43

1.53

1.1

1.4

—

(3049506) Microalbumin [Mass/time] in Urine collected for unspecified duration

200

1.55

1.53

1.8

2.1

ug/min

64.7

105.8

0.40

(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing

153

1.64

1.53

1.0

—

(3017312) HC gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

3.34

1.52

1.0

—

(3009508) Creatinine [Moles/volume] in Urine

1130

10656

1.08

1.52

3.7

3.2

mmol/l

6.7

7.4

6.05

914

8779

(4027681)

123

1.71

1.50

1.2

—

(3000764) Benzodiazepines [Presence] in Urine

343

1.40

1.46

2.2

1.9

—

(3001684) Respiratory syncytial virus Ag [Presence] in Specimen

2.23

1.46

2.1

1.0

—

(3035457) Cefaclor IgE Ab [Units/volume] in Serum

2.73

1.43

1.2

1.1

—

(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain

411

0.65

1.40

1.3

1.5

—

(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma

1489

15563

0.93

1.40

5.0

5.4

ug/l

5.5

4.3

0.22

1261

13810

(3028300) Cannabinoids [Presence] in Urine

347

1.39

1.38

2.2

1.9

—

(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma

2.08

1.38

1.8

1.7

—

(3009871) Measles virus Ab [Titer] in Serum

2.08

1.38

1.6

—

(40760871) Heparin induced platelet Ab [Presence] in Serum or Plasma by Immunoassay

2.61

1.36

1.2

1.1

—

(3004446) Plasmodium sp identified in Blood by Light microscopy

2.94

1.36

2.2

2.6

—

(40761545) Erythrocytes.dysmorphic [Presence] in Urine sediment by Light microscopy

2.94

1.36

1.2

1.1

—

(3050449) Albumin [Mass/time] in Urine collected for unspecified duration

113

924

1.23

1.33

2.4

2.3

ug/min

183.5

89.8

0.91

538

(3012516) Albumin [Mass/volume] in Urine

1102

10432

1.08

1.33

3.8

3.3

mg/l

513.7

303.3

0.81

766

6759

(3034037) Hematocrit [Volume Fraction] of Mixed venous blood

1.97

1.32

5.3

8.3

—

(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence

2.10

1.30

2.2

1.0

—

(3038177) Helicobacter pylori Ab [Presence] in Serum

369

1.36

1.29

1.3

1.4

—

(21493619) Chromosome 12 trisomy and chromosome region 11q22.3 and 13q14 and 17p13.1 deletion in Blood or Tissue by FISH

2.78

1.28

1.4

1.1

—

(3027008) Opiates [Presence] in Urine

344

1.37

1.28

2.2

1.9

—

(1001926) Buprenorphine [Presence] in Urine by Screen method

268

1.42

1.27

2.1

1.9

—

(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay

294

1.40

1.26

1.1

—

(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma

2232

21679

1.07

1.24

4.3

3.7

pmol/l

15.2

15.0

3.19

1980

19237

(3025927) Herpes simplex virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

2.22

1.24

1.0

1.2

—

(3027944) Amphetamines [Presence] in Urine

338

1.37

1.23

2.2

1.8

—

(3004775) Volume in Urine collected for unspecified duration

304

1.39

1.23

1.7

2.2

725.2

629.3

0.73

181

(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma

227

0.57

1.21

1.3

1.6

—

(3012741) Chlamydophila pneumoniae IgA Ab [Titer] in Serum

2.31

1.18

1.0

—

(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma

128

0.47

1.16

1.2

1.5

—

(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture

150

1.54

1.14

1.0

1.1

—

(3018387) Mycoplasma pneumoniae IgG Ab [Units/volume] in Serum

326

1.35

1.14

1.1

—

9.0

—

(3043410) Blood group antigens tested for on Red Blood Cells

1.69

1.13

1.4

2.2

—

(3018993) Complement total hemolytic CH100 [Units/volume] in Serum or Plasma

2.34

1.12

1.0

1.2

—

(3017962) TCRG gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

2.26

1.10

1.1

1.3

—

(3023323) Follitropin [Units/volume] in Serum or Plasma

478

1.28

1.08

1.4

iu/l

25.9

31.1

0.64

404

(36660697) Celiac disease serology panel - Serum

215

1899

1.14

1.08

1.2

—

(42869858) Acute and chronic leukemia fusion transcript panel - Blood or Tissue by Molecular genetics method

2.19

1.08

1.0

1.1

—

(4034850)

1006

0.82

1.01

18.3

11.6

—

(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative

1.77

1.00

1.1

1.3

—

(3005136) Cladosporium herbarum IgE Ab [Units/volume] in Serum

134

0.52

0.98

1.3

1.0

—

0.4

—

(40761516) BRAF gene p.Val600Glu [Presence] in Tissue by Molecular genetics method

2.18

0.98

1.0

—

(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH

132

1.52

0.97

1.2

1.1

—

(3016879) Cocaine [Presence] in Urine

320

1.32

0.94

2.3

1.9

—

(3016543) Leukocytes [#/volume] in Cerebral spinal fluid

599

1.22

0.91

1.5

1.4

e6/l

41.1

26.0

0.19

466

(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid

599

1.22

0.91

1.5

e6/l

26186.8

730.7

0.48

488

(40760847) Basement membrane Ab [Titer] in Serum by Immunofluorescence

253

1.35

0.90

1.1

1.4

titre

372.0

188.2

—

(3029790) Creatine kinase.MB [Enzymatic activity/volume] in Serum or Plasma

2.07

0.89

1.0

1.1

u/l

7.8

12.1

—

(3016914) Bacteria identified in Cerebral spinal fluid by Culture

280

1.32

0.88

1.3

1.5

—

(3048402) Erythrocytes [#/area] in Urine sediment by Automated count

194

1.39

0.88

2.1

1.7

u/field

1.5

2.3

0.49

136

(3027231) Wheat IgE Ab [Units/volume] in Serum

2.00

0.87

1.0

—

(3011288) Drugs identified in Urine by Screen method

230

1.35

0.84

2.4

2.8

—

(3042810) Amyloid beta 42 peptide [Mass/volume] in Cerebral spinal fluid

239

0.67

0.84

1.0

ng/l

738.8

656.2

—

141

(43055225) Phosphorylated tau 181 [Mass/volume] in Cerebral spinal fluid by Immunoassay

239

0.67

0.84

1.0

ng/l

49.2

44.6

—

142

(3011335) Digoxin [Mass/volume] in Serum or Plasma

1.78

0.84

2.3

2.7

—

(3000242) Tau protein [Mass/volume] in Cerebral spinal fluid

237

0.67

0.81

1.1

1.0

ng/l

571.2

314.4

—

144

(3006653) Thiamine [Moles/volume] in Blood

138

1.45

0.81

1.7

1.2

nmol/l

138.2

140.5

0.07

138

(3045424) Erythrocytes [Presence] in Urine

508

1.22

0.81

1.4

—

(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal

1152

0.86

0.81

1.1

1.0

—

(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma

154

1363

1.13

0.81

1.2

iu/ml

112.2

136.1

0.31

472

(3037534) Parathyrin related protein [Mass/volume] in Serum or Plasma

1.73

0.79

2.7

1.7

ng/l

187.4

146.0

—

(3048522) Glucose [Moles/volume] in Serum or Plasma --pre dose glucose

0.00

0.79

0.0

1.2

—

(3041365) Herpes simplex virus IgG Ab [Units/volume] in Serum by Immunoassay

1.82

0.79

1.2

—

(3034368) Herpes virus 6 IgM Ab [Presence] in Cerebral spinal fluid

0.00

0.77

0.0

1.1

—

(3047007) Chlamydophila sp Ab [Presence] in Serum

287

1.29

0.77

1.2

—

(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum

0.00

0.76

0.0

1.0

—

(1002183) Plasma cells monotypic population [Identifier] in Bone marrow by Flow cytometry (FC)

1.64

0.73

1.1

1.3

—

(3036670) Protein [Mass/volume] in Synovial fluid

108

1.48

0.73

1.3

1.2

g/l

33.8

39.4

—

(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum

442

1.22

0.73

1.1

iu/ml

93.3

64.1

—

(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection

117

1.45

0.71

1.4

1.3

—

(3051014) Leukocytes [#/area] in Urine sediment by Automated count

336

1.25

0.70

1.9

2.0

u/field

1.9

0.02

121

(4146454)

409

1.23

0.69

2.7

—

(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma

170

1.35

0.67

1.1

1.4

nmol/l

0.1

0.2

3.15

132

(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid

1.63

0.66

1.0

—

(3043525) Herpes simplex virus Ab [Presence] in Cerebral spinal fluid

1.59

0.65

1.0

1.2

—

(42868417) European tick borne encephalitis virus IgG Ab [Presence] in Serum by Immunoassay

1.61

0.65

1.0

1.2

—

(40760848) Basement membrane zone BP180 Ab [Units/volume] in Serum by Immunoassay

304

1.25

0.65

1.8

1.7

u/ml

36.5

26.6

0.57

(44813793)

137

1.39

0.64

1.1

1.0

—

(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma

3181

31468

1.05

0.64

19.8

10.8

u/l

24.7

25.7

1.37

3076

30037

(3023709) Somatotropin [Mass/volume] in Serum or Plasma

1.50

0.63

3.4

2.0

ug/l

0.8

1.3

1.04

(3015616) Isopropanol [Moles/volume] in Serum or Plasma

1.67

0.61

1.0

1.3

—

(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection

476

0.82

0.59

1.4

1.3

—

(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma

157

1.34

0.59

2.4

1.5

—

(3043257) Herpes virus 6 IgG Ab [Presence] in Cerebral spinal fluid

0.00

0.58

0.0

1.1

—

(4024509)

320

0.78

0.57

2.0

1.5

—

(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting

634

1.15

0.56

1.9

1.5

nmol/l

0.9

0.8

0.11

514

(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection

1.46

0.54

1.1

—

(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection

151

1.33

0.53

1.2

—

(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection

151

1.33

0.53

1.2

—

(3050129) First trimester maternal screen panel - Serum or Plasma

146

0.68

0.52

1.6

1.4

—

(40760007) HIV 1+2 Ab+HIV1 p24 Ag [Presence] in Serum or Plasma by Immunoassay

1.50

0.51

1.0

1.2

—

(3041870) Hepatitis C virus IgG Ab [Presence] in Serum or Plasma by Immunoassay

1.50

0.51

1.0

1.2

—

(3014051) Protein [Presence] in Urine by Test strip

746

0.87

0.51

2.8

2.3

—

(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection

109

1.38

0.50

1.0

—

(3020650) Glucose [Presence] in Urine

1.39

0.50

1.2

1.5

—

(3047166) Epithelial cells [#/area] in Urine sediment by Automated count

1.56

0.49

2.6

2.5

u/field

1.4

0.3

—

(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture

324

3063

1.06

0.48

1.3

—

(3023365) Varicella zoster virus Ab [Titer] in Cerebral spinal fluid

1.49

0.47

1.0

1.2

—

(44806420)

137

1.32

0.47

1.9

2.5

—

(3039355) Methicillin resistant Staphylococcus aureus [Presence] in Nose by Organism specific culture

1.46

0.46

2.1

2.3

—

(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection

1.43

0.46

1.0

1.5

—

(3018301) Testosterone Free [Moles/volume] in Serum or Plasma

176

0.74

0.46

1.2

1.4

pmol/l

45.2

215.1

—

(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

0.62

0.45

1.0

1.1

—

(3022689) Creatine [Moles/volume] in Urine

0.61

0.45

1.0

1.6

—

(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay

629

1.13

0.44

1.1

u/ml

9.5

9.6

—

(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture

128

0.70

0.43

1.0

1.1

—

(3014038) Collagen crosslinked N-telopeptide [Moles/volume] in Urine

1.56

0.42

1.2

1.5

—

(3005011) Chlamydia sp Ab [Titer] in Serum

1.52

0.41

1.4

1.7

—

(40761871) Peanut recombinant (rAra h) 3 IgE Ab [Units/volume] in Serum

0.00

0.41

0.0

1.0

—

0.0

—

(42528717) Cashew nut recombinant (rAna o) 3 IgE Ab [Units/volume] in Serum

0.00

0.41

0.0

1.0

—

0.0

—

(3012413) Glucose [Moles/volume] in Serum or Plasma --2 hours post meal

213

1.22

0.40

1.2

mmol/l

12.0

11.8

0.04

(3004280) Aldosterone [Moles/volume] in Serum or Plasma --supine

0.00

0.40

0.0

1.0

—

131.2

—

(3001729) Color of Synovial fluid

1.43

0.39

2.2

1.3

—

(3041008) Bicarbonate [Moles/volume] standard in Arterial cord blood

1.43

0.39

1.8

1.4

mmol/l

24.9

20.8

—

(3025018) Bordetella pertussis Ab [Titer] in Serum

115

0.70

0.37

1.1

1.2

—

(3004409) Coagulation factor X activity actual/normal in Platelet poor plasma by Coagulation assay

1.29

0.36

1.2

1.4

65.3

78.2

—

(3011547) Coagulation factor VII activity actual/normal in Platelet poor plasma by Coagulation assay

1.27

0.36

1.4

1.2

83.8

89.8

—

(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]

0.63

0.35

1.0

1.4

—

(1175556) inFLIXimab Ab [Units/volume] in Serum by Immunoassay

1.30

0.33

2.2

2.7

au/ml

—

78.6

—

(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method

378

1.14

0.33

1.0

1.1

—

(46235760) Methicillin resistant Staphylococcus aureus [Presence] in Pharynx by Organism specific culture

1.28

0.32

2.2

2.3

—

(3034988) Calcium [Moles/volume] in Capillary blood

1.35

0.32

2.0

1.6

mmol/l

1.1

1.2

—

(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay

696

0.90

0.32

2.1

1.7

—

(3006270) Folate [Moles/volume] in Blood

323

1.15

0.31

1.1

1.2

nmol/l

321.0

332.1

0.12

252

(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)

2805

27846

1.02

0.28

34.5

15.8

ml/min/173m2

71.2

73.6

5.60

2491

23061

(4133840)

1.29

0.28

1.0

1.1

—

(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

149

1.21

0.27

1.0

1.1

—

(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain

119

0.76

0.27

1.3

1.4

—

(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

1.28

0.26

1.0

1.1

—

(3051101) Glucose [Moles/volume] in Cord blood

1.23

0.25

3.2

5.8

—

(3019150) Specific gravity of Urine by Refractometry

700

6850

1.03

0.25

5.2

4.3

kg/l

1.0

0.07

110

1066

(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay

142

1.20

0.24

1.1

—

(1617658) Protocol used for examination of sentinel lymph nodes

170

1.18

0.24

1.1

1.0

—

(3022145) Colonoscopy Study observation

344

3335

1.03

0.23

1.3

—

(42529188) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma by Immunoassay

1.25

0.22

1.0

1.1

—

(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum

1.27

0.22

1.0

1.1

miu/ml

1909.9

1592.1

—

(3037556) Urate [Mass/volume] in Serum or Plasma

116

1.21

0.22

1.9

1.5

—

(40767665) Peanut recombinant (rAra h) 9 IgE Ab [Units/volume] in Serum

0.00

0.21

0.0

1.0

—

3.1

—

(3017937) Magnesium [Moles/time] in 24 hour Urine

0.00

0.21

0.0

1.2

—

(3024263) Appearance of Synovial fluid

188

0.85

0.21

2.0

1.6

—

(3011841) English Walnut IgE Ab [Units/volume] in Serum

0.00

0.21

0.0

1.0

—

0.0

—

(3025378) Microscopic observation [Identifier] in Cervix by Cyto stain

0.00

0.21

0.0

1.3

—

(3017461) Flecainide [Moles/volume] in Serum or Plasma

0.00

0.20

0.0

1.4

—

0.9

—

(40761873) Peanut recombinant (rAra h) 1 IgE Ab [Units/volume] in Serum

0.00

0.20

0.0

1.0

—

0.1

—

(3033319) Streptococcus pyogenes Ag [Presence] in Throat

120

1261

0.95

0.20

1.3

—

(3035933) Granulocytes/100 leukocytes in Blood

1.25

0.20

1.7

1.3

—

(3000963) Hemoglobin [Mass/volume] in Blood

3239

32521

0.98

0.19

53.7

24.4

g/l

124.8

133.8

159.64

3178

31852

(3015076) Soybean IgE Ab [Units/volume] in Serum

1.15

0.19

1.2

1.1

—

0.7

—

(3010813) Leukocytes [#/volume] in Blood

3240

32527

0.98

0.19

53.4

24.3

e9/l

7.5

6.9

17.77

3144

31335

(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum

1.13

0.18

1.8

1.3

—

(3026361) Erythrocytes [#/volume] in Blood

3239

32514

0.98

0.18

53.4

24.3

e12/l

4.2

4.4

100.00

3148

31329

(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma

443

4335

1.02

0.18

14.8

8.2

—

(3035941) MCH [Entitic mass]

3239

32512

0.98

0.18

53.1

24.1

30.2

30.5

13.34

3172

31834

(3024731) MCV [Entitic volume]

3239

32512

0.98

0.18

53.2

24.2

91.9

91.7

1.90

3172

31833

(3027923) C peptide [Moles/volume] in Serum or Plasma

176

1.14

0.17

1.3

nmol/l

1.4

1.1

0.35

130

(3007461) Platelets [#/volume] in Blood

3239

32508

0.98

0.17

53.4

24.3

e9/l

249.6

238.0

13.49

3151

31448

(3003888) Timothy IgE Ab [Units/volume] in Serum

224

1.12

0.17

1.1

u/ml

1.2

4.8

2.73

108

(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy

148

1.15

0.16

1.2

1.6

—

(3053028) Streptococcus sp identified in Specimen by Organism specific culture

101

1.19

0.16

1.1

1.2

—

(3028679) Herpes simplex virus Ab [Presence] in Serum

101

1.19

0.16

1.2

1.1

—

(3036035) von Willebrand factor (vWf) Ag actual/normal in Platelet poor plasma by Immunoassay

1.13

0.16

2.1

2.3

176.5

192.0

—

(3045414) Leukocytes [Presence] in Urine

134

1393

0.96

0.16

2.2

1.9

—

(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid

1.20

0.16

1.0

1.1

—

(3025130) Human papilloma virus identified in Specimen

149

1.14

0.15

2.0

1.8

—

(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma

0.78

0.14

1.3

1.7

—

(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

1.17

0.13

1.0

1.1

—

(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection

104

1002

1.04

0.12

1.4

1.7

—

(40768793) Breast Pathology biopsy report

494

1.05

0.11

1.3

—

(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid

1.16

0.11

1.0

1.1

—

(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid

1.16

0.11

1.0

1.1

—

(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection

444

0.95

0.10

1.9

1.8

—

(3009201) Thyrotropin [Units/volume] in Serum or Plasma

2694

26852

1.01

0.10

5.2

4.6

mu/l

2.5

2.1

0.75

2393

23954

(3023410) Appearance of Cerebral spinal fluid

261

1.07

0.10

1.7

—

(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method

1.04

0.09

2.8

1.8

—

(3000330) Specific gravity of Urine by Test strip

189

1856

1.02

0.08

5.6

3.7

—

(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection

1.03

0.07

1.1

—

(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)

1.05

0.07

1.0

1.4

—

(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

163

0.92

0.07

1.0

1.1

—

(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture

0.86

0.06

1.1

1.5

—

(3023511) Choriogonadotropin [Units/volume] in Urine

119

1.09

0.06

2.0

1.3

—

(3003740) Influenza virus B Ag [Presence] in Specimen

238

1.05

0.05

1.5

1.1

—

(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum

109

0.92

0.04

1.1

—

(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma

139

0.94

0.03

7.2

6.5

—

(3002523) Influenza virus A Ag [Presence] in Specimen

240

1.04

0.03

1.5

1.1

—

(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma

412

4098

1.01

0.03

4.6

4.8

33.6

33.1

0.41

284

2636

(4211845)

171

1.05

0.03

3.8

3.9

—

(3022621) pH of Urine by Test strip

221

2227

0.99

0.03

3.3

3.2

—

(3000034) Microalbumin [Mass/volume] in Urine

340

0.97

0.03

3.2

mg/l

66.8

34.6

0.46

264

(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection

350

0.97

0.03

1.9

1.8

—

(3008401) Mugwort IgE Ab [Units/volume] in Serum

221

1.04

0.03

1.1

u/ml

0.4

2.1

—

(3032773) Endomysium IgG Ab [Titer] in Serum

202

1.04

0.02

1.0

1.1

—

(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay

288

0.97

0.02

1.0

1.1

u/ml

4.1

2.4

—

(3018980) carBAMazepine [Moles/volume] in Serum or Plasma

117

0.94

0.01

1.7

2.8

umol/l

30.0

29.5

—

(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection

111

1117

0.99

0.00

1.5

1.7

—

(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay

126

0.95

0.00

1.0

1.2

—

(3016244) Insulin [Units/volume] in Serum or Plasma

1.02

0.00

1.9

2.9

mu/l

52.1

19.4

—

(3045683) HLA typing for celiac disease panel - Blood or Tissue

112

0.98

0.00

1.0

—

(3006462) Nitrate [Presence] in Urine

155

0.97

0.00

3.9

4.2

—

(3008898) HLA-B27 [Presence]

618

1.00

0.00

1.0

1.1

—

(3051387) C reactive protein [Mass/volume] in Capillary blood

805

1.01

0.00

4.1

3.6

mg/l

33.6

31.3

0.21

519

(44816844) Macroprolactin [Units/volume] in Serum or Plasma

179

1.01

0.00

1.9

1.7

—

(3017446) Testosterone [Moles/volume] in Serum or Plasma

247

2474

1.00

0.00

2.2

2.1

nmol/l

10.7

12.0

1.28

202

2108

(3023351) European house dust mite IgE Ab [Units/volume] in Serum

264

0.98

0.00

1.1

u/ml

0.3

1.8

2.08

103

(3001218) Citrate [Mass/time] in 24 hour Urine

0.00

0.0

1.6

—

(3015147) Influenza virus A IgG Ab [Units/volume] in Serum

0.00

0.0

1.0

—

(3006567) Chloride [Moles/time] in 24 hour Urine

0.00

0.0

1.0

—

(40762887) Creatinine [Moles/volume] in Blood

0.00

0.0

1.0

—

(3034614) HLA Ag [Interpretation]

0.00

0.0

1.2

—

(3028714) Urate [Moles/time] in 24 hour Urine

0.00

0.0

1.5

—

(3019396) Amylase.pancreatic [Enzymatic activity/volume] in Urine

0.00

0.0

1.0

—

1672.6

—

(3038714) Yersinia pseudotuberculosis Ab [Titer] in Serum by Agglutination

0.00

0.0

1.0

—

(3015183) Erythrocyte sedimentation rate

0.92

0.00

1.3

1.2

—

(46236344) Yersinia enterocolitica O:9 IgG Ab [Presence] in Serum by Agglutination

0.00

0.0

1.0

—

(3018291) Platelet Ab [Presence] in Serum

0.00

0.0

1.0

—

(3042341) Yersinia pseudotuberculosis Ab [Presence] in Serum

0.00

0.0

2.0

—

(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

0.96

0.00

1.0

1.1

—

(3040668) CNBP gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal

0.00

0.0

1.0

—

(723473) SARS-CoV-2 (COVID-19) IgA Ab [Presence] in Serum or Plasma by Immunoassay

0.00

0.0

1.3

—

(3013336) Amino acids [Identifier] in Serum or Plasma

0.00

0.0

5.7

—

(3027401) Testosterone Free/Testosterone.total in Serum or Plasma

0.00

0.0

1.1

—

1.3

—

(3040944) Yersinia pseudotuberculosis 3 Ab [Titer] in Serum

0.00

0.0

1.0

—

(3033093) Yersinia sp IgM Ab [Titer] in Serum

0.00

0.0

2.0

—

(3025886) Oxalate [Mass/time] in 24 hour Urine

0.00

0.0

1.0

—

(3039817) Yersinia enterocolitica IgA Ab [Presence] in Serum

0.00

0.0

2.0

—

(40767663) Brazil Nut recombinant (rBer e) 1 IgE Ab [Units/volume] in Serum

0.00

0.0

1.0

—

(3036071) Salmonella sp Ab [Titer] in Serum

1.01

0.00

1.1

—

(3041293) ARIPiprazole [Mass/volume] in Serum or Plasma

0.00

0.0

2.0

—

Mortality – FinRegistry

↥

Association

Association between endpoint J10_PLEUROTH and mortality.

Females

Parameter	HR [95% CI]	p-value
J10_PLEUROTH	5.148 [4.33, 6.12]	< 0.001
Birth year	0.989 [0.98, 1.0]	0.013

During the follow-up period (1.1.1998 — 31.12.2019), 4491 out of 7479 females with J10_PLEUROTH died.

Males

Parameter	HR [95% CI]	p-value
J10_PLEUROTH	3.722 [3.21, 4.31]	< 0.001
Birth year	0.989 [0.98, 1.0]	0.017

During the follow-up period (1.1.1998 — 31.12.2019), 6334 out of 11188 males with J10_PLEUROTH died.

Mortality risk

Mortality risk for people of age

years, who have J10_PLEUROTH.

N-year risk	Females	Males
1	0.428%	0.56%
5	2.282%	4.013%
10	5.981%	9.919%
15	11.678%	18.879%
20	19.82%	31.195%

Relationships between endpoints

↥

Index endpoint: J10_PLEUROTH – Other pleural conditions

GWS hits: -

Endpoint

Case Overlap

Survival Analysis

Genetic Correlations

Genetic Signals

N (Jaccard index)

HR [CI]

Extremity

rg [CI]

Extremity

Hits

Coloc Hits

FinRegistry

FinnGen

FinRegistry

FinnGen

Loading data

Other pleural conditions

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

Similar endpoints

Case counts by codes

Summary Statistics

-FinRegistry-

Key figures

-FinnGen-

Key figures

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS (R11)

Matched cohort

LabWAS

Mortality – FinRegistry

Association

Females

Males

Mortality risk

Relationships between endpoints